<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26731668</article-id><article-id pub-id-type="pmc">4701161</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0145924</article-id><article-id pub-id-type="publisher-id">PONE-D-15-31495</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Retinoid Homeostatic Gene Expression in Liver, Lung and Kidney: Ontogeny and Response to Vitamin A-Retinoic Acid (VARA) Supplementation from Birth to Adult Age</article-title><alt-title alt-title-type="running-head">Ontogeny and Regulation of Vitamin A Homeostasis</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Owusu</surname><given-names>Sarah A.</given-names></name><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ross</surname><given-names>A. Catharine</given-names></name><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref><xref rid="cor001" ref-type="corresp">*</xref></contrib></contrib-group><aff id="aff001"><label>1</label><addr-line>Graduate Program in Physiology, The Pennsylvania State University, University Park, Pennsylvania, United States of America</addr-line></aff><aff id="aff002"><label>2</label><addr-line>Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America</addr-line></aff><aff id="aff003"><label>3</label><addr-line>Center for Molecular and Cellular Immunology, Huck Institute for the Life Sciences, The Pennsylvania State University, University Park, Pennsylvania, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Schubert</surname><given-names>Michael</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"></xref></contrib></contrib-group><aff id="edit1"><addr-line>Laboratoire de Biologie du Développement de Villefranche-sur-Mer, FRANCE</addr-line></aff><author-notes><fn fn-type="conflict" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con" id="contrib001"><p>Conceived and designed the experiments: SAO ACR. Performed the experiments: SAO. Analyzed the data: SAO. Wrote the paper: SAO ACR.</p></fn><corresp id="cor001">* E-mail: <email>acr6@psu.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>5</day><month>1</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>11</volume><issue>1</issue><elocation-id>e0145924</elocation-id><history><date date-type="received"><day>17</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>10</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>© 2016 Owusu, Ross</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Owusu, Ross</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0145924.pdf"></self-uri><abstract><p><offsets xml_i="4364" xml_f="4773" txt_i="11" txt_f="420">Vitamin A (VA, retinol) metabolism is homeostatically controlled, but little is known of its regulation in the postnatal period. Here, we determined the postnatal trajectory of VA storage and metabolism in major compartments of VA metabolism–plasma, liver, lung, and kidney from postnatal (P) day 1 to adulthood. We also investigated the response to supplementation with VARA, a combination of VA and 10% all-</offsets><italic><offsets xml_i="4781" xml_f="4786" txt_i="420" txt_f="425">trans</offsets></italic><offsets xml_i="4795" xml_f="5170" txt_i="425" txt_f="800">-retinoic acid that previously was shown to synergistically increase retinol uptake and storage in lung. Nursling pups of dams fed a VA-marginal diet received an oral dose of oil (placebo) or VARA on each of four neonatal days: P1, P4, P7, and P10; and again as adults. Tissues were collected 6 h after the final dosing on P1, P4, P10, and at adult age. Gene transcripts for </offsets><italic><offsets xml_i="5178" xml_f="5182" txt_i="800" txt_f="804">Lrat</offsets></italic><offsets xml_i="5191" xml_f="5196" txt_i="804" txt_f="809"> and </offsets><italic><offsets xml_i="5204" xml_f="5208" txt_i="809" txt_f="813">Rbp4</offsets></italic><offsets xml_i="5217" xml_f="5231" txt_i="813" txt_f="827"> in liver and </offsets><italic><offsets xml_i="5239" xml_f="5246" txt_i="827" txt_f="834">Raldh-1</offsets></italic><offsets xml_i="5255" xml_f="5260" txt_i="834" txt_f="839"> and </offsets><italic><offsets xml_i="5268" xml_f="5275" txt_i="839" txt_f="846">Raldh-3</offsets></italic><offsets xml_i="5284" xml_f="5349" txt_i="846" txt_f="911"> in lung, did not differ in the neonatal period but were higher, </offsets><italic><offsets xml_i="5357" xml_f="5358" txt_i="911" txt_f="912">P</offsets></italic><offsets xml_i="5367" xml_f="5394" txt_i="912" txt_f="936">&lt;0.05, in adults, while </offsets><italic><offsets xml_i="5402" xml_f="5409" txt_i="936" txt_f="943">Cyp26B1</offsets></italic><offsets xml_i="5418" xml_f="5420" txt_i="943" txt_f="945">, </offsets><italic><offsets xml_i="5428" xml_f="5433" txt_i="945" txt_f="950">Stra6</offsets></italic><offsets xml_i="5442" xml_f="5457" txt_i="950" txt_f="965">, megalin, and </offsets><italic><offsets xml_i="5465" xml_f="5472" txt_i="965" txt_f="972">Raldh-2</offsets></italic><offsets xml_i="5481" xml_f="5690" txt_i="972" txt_f="1181"> in lung did not differ from perinatal to adult ages. VARA supplementation increased total retinol in plasma, liver and lung, with a dose-by-dose accumulation in neonatal liver and lung, while transcripts for </offsets><italic><offsets xml_i="5698" xml_f="5702" txt_i="1181" txt_f="1185">Lrat</offsets></italic><offsets xml_i="5711" xml_f="5741" txt_i="1185" txt_f="1215"> in liver, megalin in kidney, </offsets><italic><offsets xml_i="5749" xml_f="5759" txt_i="1215" txt_f="1225">Cyp26A1/B1</offsets></italic><offsets xml_i="5768" xml_f="5806" txt_i="1225" txt_f="1263"> in liver and lung, respectively, and </offsets><italic><offsets xml_i="5814" xml_f="5819" txt_i="1263" txt_f="1268">Stra6</offsets></italic><offsets xml_i="5828" xml_f="5986" txt_i="1268" txt_f="1426"> in lung, were all increased, suggesting pathways of VA uptake, storage and RA oxidation were each augmented after VARA. VARA decreased hepatic expression of </offsets><italic><offsets xml_i="5994" xml_f="5998" txt_i="1426" txt_f="1430">Rbp4</offsets></italic><offsets xml_i="6007" xml_f="6079" txt_i="1430" txt_f="1502">, responsible for VA trafficking from liver to plasma, and, in lung, of </offsets><italic><offsets xml_i="6087" xml_f="6094" txt_i="1502" txt_f="1509">Raldh-1</offsets></italic><offsets xml_i="6103" xml_f="6108" txt_i="1509" txt_f="1514"> and </offsets><italic><offsets xml_i="6116" xml_f="6123" txt_i="1514" txt_f="1521">Raldh-2</offsets></italic><offsets xml_i="6132" xml_f="6497" txt_i="1521" txt_f="1886">, which function in RA production. Our results define retinoid homeostatic gene expression from neonatal and adult age and show that while supplementation with VARA acutely alters retinol content and retinoid homeostatic gene expression in neonatal and adult lung, liver and kidney, VARA supplementation of neonates increased adult-age VA content only in the liver.</offsets></p></abstract><funding-group><funding-statement>This work was supported by the National Institute of Health (RO1 HD-066982), the Pennsylvania State University Bunton-Waller Fellowship, and partial funding through Alfred P. Sloan Scholarship for PhD candidates through the Pennsylvania State University Center for Exemplary Mentoring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="5"></fig-count><table-count count="2"></table-count><page-count count="19"></page-count></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All data are presented within the paper.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All data are presented within the paper.</p></notes></front><body><sec sec-type="intro" id="sec001"><title><offsets xml_i="7474" xml_f="7486" txt_i="1894" txt_f="1906">Introduction</offsets></title><p><offsets xml_i="7497" xml_f="8274" txt_i="1907" txt_f="2684">Vitamin A (VA; retinol) is an essential micronutrient for several biological processes, including vision, embryonic development, cell differentiation, growth and development, and regulation of the immune system. The activity of VA depends on the oxidative metabolism of retinol to form retinal and retinoic acid (RA). RA functions as the most active metabolite of VA by activating nuclear transcription factors that regulate the expression of several genes, including several that are involved in the metabolism of retinol, known as retinoid homeostatic genes. VA deficiency (VAD), which may manifest in clinical deficiency or marginal states of low retinoid status, is a common form of micronutrient malnutrition affecting preschool-age children and pregnant women worldwide [</offsets><xref rid="pone.0145924.ref001" ref-type="bibr"><offsets xml_i="8322" xml_f="8323" txt_i="2684" txt_f="2685">1</offsets></xref><offsets xml_i="8330" xml_f="8332" txt_i="2685" txt_f="2687">, </offsets><xref rid="pone.0145924.ref002" ref-type="bibr"><offsets xml_i="8380" xml_f="8381" txt_i="2687" txt_f="2688">2</offsets></xref><offsets xml_i="8388" xml_f="8517" txt_i="2688" txt_f="2817">]. VA supplementation of young children is promoted by The World Health Organization as a means to reduce young child mortality [</offsets><xref rid="pone.0145924.ref001" ref-type="bibr"><offsets xml_i="8565" xml_f="8566" txt_i="2817" txt_f="2818">1</offsets></xref><offsets xml_i="8573" xml_f="9009" txt_i="2818" txt_f="3254">]. Nonetheless, there are still significant gaps in understanding VA metabolism in the neonatal period. In view of the involvement of VA in a wide variety of physiologic and metabolic systems, newborns and neonates may have a need for a higher rate of retinol oxidation and RA formation to support their rapid growth and the differentiation of tissues. However, the actual biological requirements for VA in this age group are not known.</offsets></p><p><offsets xml_i="9016" xml_f="9125" txt_i="3255" txt_f="3364">Recently, we conducted studies of retinol kinetics, using a mathematical modeling approach in neonatal rats [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="9173" xml_f="9174" txt_i="3364" txt_f="3365">3</offsets></xref><offsets xml_i="9181" xml_f="9567" txt_i="3365" txt_f="3751">], in which we compared two groups of neonatal rats, an oil-treated placebo group nursed by dams fed VA-marginal diet, and thus resembling infants of mothers with low VA status, and neonates that were supplemented with a combination of VA and RA, known as VARA. This combination contains VA given at a dose per body weight that is similar to VA given as a supplement to young children [</offsets><xref rid="pone.0145924.ref001" ref-type="bibr"><offsets xml_i="9615" xml_f="9616" txt_i="3751" txt_f="3752">1</offsets></xref><offsets xml_i="9623" xml_f="9625" txt_i="3752" txt_f="3754">, </offsets><xref rid="pone.0145924.ref002" ref-type="bibr"><offsets xml_i="9673" xml_f="9674" txt_i="3754" txt_f="3755">2</offsets></xref><offsets xml_i="9681" xml_f="9862" txt_i="3755" txt_f="3936">], plus a small portion, 10 mol-% of RA, which we previously showed increases, by approximately 5-fold, the uptake of retinol and the storage of retinyl ester in neonatal rat lung [</offsets><xref rid="pone.0145924.ref004" ref-type="bibr"><offsets xml_i="9910" xml_f="9911" txt_i="3936" txt_f="3937">4</offsets></xref><offsets xml_i="9918" xml_f="9920" txt_i="3937" txt_f="3939">, </offsets><xref rid="pone.0145924.ref005" ref-type="bibr"><offsets xml_i="9968" xml_f="9969" txt_i="3939" txt_f="3940">5</offsets></xref><offsets xml_i="9976" xml_f="10131" txt_i="3940" txt_f="4095">]. Thus, VARA could be an interesting means of increasing lung retinoid status. Although our previous studies on VARA supplementation focused on the lung [</offsets><xref rid="pone.0145924.ref004" ref-type="bibr"><offsets xml_i="10179" xml_f="10180" txt_i="4095" txt_f="4096">4</offsets></xref><offsets xml_i="10187" xml_f="10188" txt_i="4096" txt_f="4097">–</offsets><xref rid="pone.0145924.ref008" ref-type="bibr"><offsets xml_i="10236" xml_f="10237" txt_i="4097" txt_f="4098">8</offsets></xref><offsets xml_i="10244" xml_f="11329" txt_i="4098" txt_f="5183">], there currently is no integrated view of retinoid homeostatic gene expression that includes the plasma, liver, lung, and kidney throughout the neonatal period. The roles of these tissues may differ, or overlap. Thus, our objectives in the current studies were to determine the natural ontogenic development of retinoid homeostatic gene expression in the neonatal to adult periods, and to understand the response of these major organs to VARA supplementation, at neonatal and adult ages. Plasma is important for distributing retinol between all other tissues through the binding of retinol to retinol-binding protein (RBP). The liver esterifies retinol using the enzyme lecithin:retinol acyltransferase (LRAT), thus storing VA as retinyl ester; it also oxidizes retinoids, and synthesizes RBP. The lung is a prototypical extrahepatic VA target tissue that not only stores VA as retinyl ester but also is capable of producing RA and catabolizing retinoids. The kidney is the major site of RBP uptake by megalin, a multi-ligand receptor that functions to conserve and recycle retinol [</offsets><xref rid="pone.0145924.ref009" ref-type="bibr"><offsets xml_i="11377" xml_f="11378" txt_i="5183" txt_f="5184">9</offsets></xref><offsets xml_i="11385" xml_f="11387" txt_i="5184" txt_f="5186">, </offsets><xref rid="pone.0145924.ref010" ref-type="bibr"><offsets xml_i="11435" xml_f="11437" txt_i="5186" txt_f="5188">10</offsets></xref><offsets xml_i="11444" xml_f="12782" txt_i="5188" txt_f="6526">]. In the present study, we have quantified retinol concentrations and retinoid homeostatic gene expression, with and without VARA supplementation, during the period of postnatal development (i.e., normal ontogeny, from birth to adult age) in each of these tissues in order to understand which components of this homeostatic system are responsive to VARA supplementation, and when. We also wanted to learn whether treatment of neonates with VARA has any long-term impact (“carry over effect”) at adult age. Thus, our study addresses three questions: 1) Is there a natural ontogenic progression of tissue VA and retinoid homeostatic gene expression in the neonates of mothers fed VA-marginal diet, and in adults fed VA-marginal diet from weaning? 2) Does VARA supplementation given periodically during the neonatal period affect the expression of retinoid homeostatic genes, either transiently or in a cumulative manner? 3) Does VARA supplementation of neonates have a long-term consequence on retinoid homeostatic gene expression in adults? Together, our results demonstrate significant developmental changes in the levels of some retinoid homeostatic genes, while not others, and reveal that neonatal VARA supplementation results in both short-term changes, and, for certain genes, a prolonged effect that is evident in the adult animal.</offsets></p></sec><sec sec-type="materials|methods" id="sec002"><title><offsets xml_i="12845" xml_f="12866" txt_i="6528" txt_f="6549">Methods and Materials</offsets></title><sec id="sec003"><title><offsets xml_i="12898" xml_f="12936" txt_i="6550" txt_f="6588">Animals, diet and experimental designs</offsets></title><p><offsets xml_i="12947" xml_f="13355" txt_i="6589" txt_f="6997">The Institutional Animal Use and Care Committee of The Pennsylvania State University approved animal procedures for care and use. Rats were housed in a room maintained at 22°C with a 12:12-h dark-light cycle, and food and water were freely available. A VA-marginal (VAM) purified diet (0.35 mg retinol equivalents/kg diet, AIN-93G diet prepared by Research Diets, New Brunswick, NJ) as previously described [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="13403" xml_f="13404" txt_i="6997" txt_f="6998">3</offsets></xref><offsets xml_i="13411" xml_f="13695" txt_i="6998" txt_f="7282">] was fed to mating adult Sprague-Dawley female and male rats. After mating, pregnant dams maintained VAM diet in order to reduce the transfer of VA in milk from mother to pups during lactation in order to mimic the physiological state of low VA status observed in human populations [</offsets><xref rid="pone.0145924.ref011" ref-type="bibr"><offsets xml_i="13743" xml_f="13745" txt_i="7282" txt_f="7284">11</offsets></xref><offsets xml_i="13752" xml_f="14037" txt_i="7284" txt_f="7569">]. At birth, pups were randomly assigned to age of observation (P1, P4, P10, and adult) and treatment groups, VARA or placebo (canola oil). The neonatal ages of observation were selected to represent the pre-, early, and mid-septation stages of postnatal lung development. As shown in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="14082" xml_f="14088" txt_i="7569" txt_f="7575">Fig 1A</offsets></xref><offsets xml_i="14095" xml_f="14272" txt_i="7575" txt_f="7752">, on the day of dosing (P1, P4, P7, P10 and 2 months), each pup received a single oral dose delivered directly into the mouth via a small micropipette, as previously described [</offsets><xref rid="pone.0145924.ref004" ref-type="bibr"><offsets xml_i="14320" xml_f="14321" txt_i="7752" txt_f="7753">4</offsets></xref><offsets xml_i="14328" xml_f="14329" txt_i="7753" txt_f="7754">–</offsets><xref rid="pone.0145924.ref006" ref-type="bibr"><offsets xml_i="14377" xml_f="14378" txt_i="7754" txt_f="7755">6</offsets></xref><offsets xml_i="14385" xml_f="15009" txt_i="7755" txt_f="8379">]. The volume of each dose was ~0.4 μL/g body wt adjusted after weighing. After dosing, each pre-weaned pup was returned to the mother. Weaned and post-weaned rats were fed the same VAM diet as mother. Rats were euthanized 6 h after final VARA or placebo treatment at randomly assigned age. Therefore, at P10, pups would have received an oral treatment at P1, P4, P7, and 6 h prior to tissue collection at P10 for a total of 4 treatments. Animals used to analyze VARA neonatal carry over effect in adult rats received oral dose at neonatal ages mentioned above (P1, P4, P7, and P10), but not prior to euthanasia as an adult.</offsets></p><fig id="pone.0145924.g001" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="15110" xml_f="15143" txt_i="8380" txt_f="8413">10.1371/journal.pone.0145924.g001</offsets></object-id><label><offsets xml_i="15162" xml_f="15167" txt_i="8413" txt_f="8418">Fig 1</offsets></label><caption><title><offsets xml_i="15191" xml_f="15353" txt_i="8418" txt_f="8580">Experimental design and total retinol concentrations in plasma, liver, and lung of neonatal rats to adult-age rats fed VAM diet supplemented with or without VARA.</offsets></title><p><offsets xml_i="15364" xml_f="16280" txt_i="8581" txt_f="9497">Experimental design and treatment schedule (1A), and total retinol concentrations in plasma (B), liver (C), and lung (D) of control (oil-treated) neonates nursed by dams fed vitamin A marginal (VAM) diet, oil placebo) and VARA supplemented rats at postnatal day (P)1, P4, P10 and adult age. Sprague-Dawley offspring were generated by mating female and male rats; dams were fed marginal VA diet, which was maintained throughout gestation and postnatally, and after weaning in the offspring that reached adult age. Pups were randomly assigned to receive oil or VARA treatments at five ages. The adult group marked 0 received VARA at neonatal days P1-P10, but not at adult age, to assess any carry over effect of neonatal VARA supplementation at adult age. For all ages, the final treatment with oil or VARA was administered 6 h before euthanasia and tissue collection (A). Data in B, C, and D are shown as mean ± SEM, </offsets><italic><offsets xml_i="16288" xml_f="16289" txt_i="9497" txt_f="9498">n</offsets></italic><offsets xml_i="16298" xml_f="16503" txt_i="9498" txt_f="9703"> ≥ 5/group. One-way ANOVA with posthoc analysis was used to determine differences between oil-treated groups, indicative of differences due to ontogeny; means without a common letter differ significantly, </offsets><italic><offsets xml_i="16511" xml_f="16512" txt_i="9703" txt_f="9704">P</offsets></italic><offsets xml_i="16521" xml_f="16587" txt_i="9704" txt_f="9767"> &lt; 0.05. For each age, VARA versus Oil groups were compared by </offsets><italic><offsets xml_i="16595" xml_f="16596" txt_i="9767" txt_f="9768">t</offsets></italic><offsets xml_i="16605" xml_f="16624" txt_i="9768" txt_f="9787">-test; * indicates </offsets><italic><offsets xml_i="16632" xml_f="16633" txt_i="9787" txt_f="9788">P</offsets></italic><offsets xml_i="16642" xml_f="16836" txt_i="9788" txt_f="9979"> &lt; 0.05. In C, linear trends with age were determined for the Oil and VARA groups separately. Abbreviations: P, postnatal day; VAM, vitamin A marginal; VARA, vitamin A with 10% retinoic acid.</offsets></p></caption><graphic xlink:href="pone.0145924.g001"></graphic></fig></sec><sec id="sec004"><title><offsets xml_i="16936" xml_f="16952" txt_i="9981" txt_f="9997">Dose preparation</offsets></title><p><offsets xml_i="16963" xml_f="16985" txt_i="9998" txt_f="10020">VA in the form of all-</offsets><italic><offsets xml_i="16993" xml_f="16998" txt_i="10020" txt_f="10025">trans</offsets></italic><offsets xml_i="17007" xml_f="17141" txt_i="10025" txt_f="10159">-retinyl palmitate was generously provided by Vitamin Angels (Santa Barbara, CA) or purchased from Sigma-Aldrich (St. Louis, MO). All-</offsets><italic><offsets xml_i="17149" xml_f="17154" txt_i="10159" txt_f="10164">trans</offsets></italic><offsets xml_i="17163" xml_f="17307" txt_i="10164" txt_f="10308">-RA was also purchased from Sigma-Aldrich. Preparation as previously described of VARA was a mixture of VA dose and one-tenth the amount of RA [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="17355" xml_f="17356" txt_i="10308" txt_f="10309">3</offsets></xref><offsets xml_i="17363" xml_f="17430" txt_i="10309" txt_f="10376">]. Retinoids were stored in -20°C and protected from air and light.</offsets></p></sec><sec id="sec005"><title><offsets xml_i="17464" xml_f="17481" txt_i="10378" txt_f="10395">Tissue collection</offsets></title><p><offsets xml_i="17492" xml_f="17778" txt_i="10396" txt_f="10682">After rats were killed at designated times, heparinized blood was collected from the vena cava for plasma preparation and stored at -20°C. The lungs, liver, and kidneys were removed, trimmed and weighed, and then frozen in liquid nitrogen and stored at -80°C prior to retinoid analysis.</offsets></p></sec><sec id="sec006"><title><offsets xml_i="17812" xml_f="17829" txt_i="10684" txt_f="10701">Retinoid analysis</offsets></title><p><offsets xml_i="17840" xml_f="18011" txt_i="10702" txt_f="10873">Plasma, lung and liver tissues were analyzed for total retinol after saponification. Extraction, saponification, and UPLC analysis were conducted as previously described [</offsets><xref rid="pone.0145924.ref012" ref-type="bibr"><offsets xml_i="18059" xml_f="18061" txt_i="10873" txt_f="10875">12</offsets></xref><offsets xml_i="18068" xml_f="18272" txt_i="10875" txt_f="11076">] using trimethylmethoxyphenyl-retinol as an internal standard. In tissues, &gt;90% of total retinol is esterified, therefore total retinol represent RE + retinol in our studies. Retinal was not detected.</offsets></p></sec><sec id="sec007"><title><offsets xml_i="18306" xml_f="18335" txt_i="11078" txt_f="11107">Gene mRNA level determination</offsets></title><p><offsets xml_i="18346" xml_f="18451" txt_i="11108" txt_f="11213">Total RNA from the liver, lungs, and kidneys of individual pup and adult rats were extracted using Trizol</offsets><sup><offsets xml_i="18456" xml_f="18457" txt_i="11213" txt_f="11214">®</offsets></sup><offsets xml_i="18463" xml_f="18566" txt_i="11214" txt_f="11317"> reagent (Life Technologies) and complementary DNA was prepared using reverse transcriptase (Promega) [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="18614" xml_f="18616" txt_i="11317" txt_f="11319">13</offsets></xref><offsets xml_i="18623" xml_f="18855" txt_i="11319" txt_f="11551">]. The diluted reaction product was used for quantitative real-time PCR analysis using 2X Real SYBR Green PCR Master Mix (BioRad, Hercules, CA), and qPCR was performed using the DNA Engine2 Opticon (BioRad) as previously described [</offsets><xref rid="pone.0145924.ref012" ref-type="bibr"><offsets xml_i="18903" xml_f="18905" txt_i="11551" txt_f="11553">12</offsets></xref><offsets xml_i="18912" xml_f="18965" txt_i="11553" txt_f="11606">]. All primers were designed to detect mRNA for rat (</offsets><xref rid="pone.0145924.t001" ref-type="table"><offsets xml_i="19012" xml_f="19019" txt_i="11606" txt_f="11613">Table 1</offsets></xref><offsets xml_i="19026" xml_f="19029" txt_i="11613" txt_f="11616">). </offsets><italic><offsets xml_i="19037" xml_f="19041" txt_i="11616" txt_f="11620">Lrat</offsets></italic><offsets xml_i="19050" xml_f="19065" txt_i="11620" txt_f="11635"> (NM_02280.2), </offsets><italic><offsets xml_i="19073" xml_f="19080" txt_i="11635" txt_f="11642">Cyp26B1</offsets></italic><offsets xml_i="19089" xml_f="19107" txt_i="11642" txt_f="11660"> (NM_181087), and </offsets><italic><offsets xml_i="19115" xml_f="19120" txt_i="11660" txt_f="11665">Stra6</offsets></italic><offsets xml_i="19129" xml_f="19178" txt_i="11665" txt_f="11714"> (NM_0010029924.1) were as previously described [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="19226" xml_f="19228" txt_i="11714" txt_f="11716">13</offsets></xref><offsets xml_i="19235" xml_f="19273" txt_i="11716" txt_f="11754">]. Primer sets were also designed for </offsets><italic><offsets xml_i="19281" xml_f="19286" txt_i="11754" txt_f="11759">Gapdh</offsets></italic><offsets xml_i="19295" xml_f="19309" txt_i="11759" txt_f="11773"> (NM_017008) [</offsets><xref rid="pone.0145924.ref014" ref-type="bibr"><offsets xml_i="19357" xml_f="19359" txt_i="11773" txt_f="11775">14</offsets></xref><offsets xml_i="19366" xml_f="19381" txt_i="11775" txt_f="11790">] and megalin (</offsets><italic><offsets xml_i="19389" xml_f="19393" txt_i="11790" txt_f="11794">Lrp2</offsets></italic><offsets xml_i="19402" xml_f="19418" txt_i="11794" txt_f="11810">; NM_030827.1) [</offsets><xref rid="pone.0145924.ref015" ref-type="bibr"><offsets xml_i="19466" xml_f="19468" txt_i="11810" txt_f="11812">15</offsets></xref><offsets xml_i="19475" xml_f="19657" txt_i="11812" txt_f="11994">]. The mRNA expression level for each liver and kidney sample was normalized by calculating the mRNA-to-ribosomal 18S RNA ratio and each lung sample was normalized by reference gene </offsets><italic><offsets xml_i="19665" xml_f="19670" txt_i="11994" txt_f="11999">Gapdh</offsets></italic><offsets xml_i="19679" xml_f="19787" txt_i="11999" txt_f="12107">. Data were normalized to the average value for the P1 oil group, set at 1.00 prior to statistical analysis.</offsets></p><table-wrap id="pone.0145924.t001" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="19895" xml_f="19928" txt_i="12108" txt_f="12141">10.1371/journal.pone.0145924.t001</offsets></object-id><label><offsets xml_i="19947" xml_f="19954" txt_i="12141" txt_f="12148">Table 1</offsets></label><caption><title><offsets xml_i="19978" xml_f="20015" txt_i="12148" txt_f="12185">Genes analyzed and primer pairs used.</offsets></title></caption><alternatives><graphic id="pone.0145924.t001g" xlink:href="pone.0145924.t001"></graphic><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"><offsets xml_i="20436" xml_f="20440" txt_i="12186" txt_f="12190">Gene</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="20486" xml_f="20499" txt_i="12190" txt_f="12203">Accession No.</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="20545" xml_f="20554" txt_i="12203" txt_f="12212">Sequences</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="20600" xml_f="20614" txt_i="12212" txt_f="12226">Mode of Action</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20690" xml_f="20705" txt_i="12226" txt_f="12241">Cytochrome P450</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="20758" xml_f="20769" txt_i="12242" txt_f="12253">NM_130408.2</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="20922" xml_f="20959" txt_i="12256" txt_f="12293">family 26, subfamily A, polypeptide 1</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="21012" xml_f="21026" txt_i="12294" txt_f="12308">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="21083" xml_f="21107" txt_i="12309" txt_f="12333">5' -GCACTCATGGGAGAGAGGAG</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="21165" xml_f="21223" txt_i="12334" txt_f="12392">Terminal oxidation of retinoic acid to polar metabolites [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="21271" xml_f="21273" txt_i="12392" txt_f="12394">13</offsets></xref><offsets xml_i="21280" xml_f="21281" txt_i="12394" txt_f="12395">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21342" xml_f="21351" txt_i="12396" txt_f="12405">(CYP26A1)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="21404" xml_f="21418" txt_i="12406" txt_f="12420">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="21475" xml_f="21499" txt_i="12421" txt_f="12445">5' -GGGGGCTTGTCTTCATTGTA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21618" xml_f="21633" txt_i="12447" txt_f="12462">Cytochrome P450</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="21686" xml_f="21695" txt_i="12463" txt_f="12472">NM_181087</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="21848" xml_f="21885" txt_i="12475" txt_f="12512">family 26, subfamily B, polypeptide 1</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="21938" xml_f="21952" txt_i="12513" txt_f="12527">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="22009" xml_f="22032" txt_i="12528" txt_f="12551">5' -TTGAGGGCTTGGAGTTGGT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="22090" xml_f="22148" txt_i="12552" txt_f="12610">Terminal oxidation of retinoic acid to polar metabolites [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="22196" xml_f="22198" txt_i="12610" txt_f="12612">13</offsets></xref><offsets xml_i="22205" xml_f="22206" txt_i="12612" txt_f="12613">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="22267" xml_f="22276" txt_i="12614" txt_f="12623">(CYP26B1)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="22329" xml_f="22343" txt_i="12624" txt_f="12638">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="22400" xml_f="22424" txt_i="12639" txt_f="12663">5' -AACGTTGCCATACTTCTCGC</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="22543" xml_f="22575" txt_i="12665" txt_f="12697">Lecithin retinol acyltransferase</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="22628" xml_f="22639" txt_i="12698" txt_f="12709">NM_022280.2</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="22792" xml_f="22798" txt_i="12712" txt_f="12718">(LRAT)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="22851" xml_f="22865" txt_i="12719" txt_f="12733">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="22922" xml_f="22946" txt_i="12734" txt_f="12758">5' -CGGACCCATTTTACCCACTA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23004" xml_f="23053" txt_i="12759" txt_f="12808">Esterification of retinol necessary for storage [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="23101" xml_f="23103" txt_i="12808" txt_f="12810">13</offsets></xref><offsets xml_i="23110" xml_f="23111" txt_i="12810" txt_f="12811">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23212" xml_f="23226" txt_i="12813" txt_f="12827">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="23283" xml_f="23307" txt_i="12828" txt_f="12852">5' -CAGACTGCAGGAAGGGTCAT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="23426" xml_f="23433" txt_i="12854" txt_f="12861">Megalin</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23486" xml_f="23497" txt_i="12862" txt_f="12873">NM_030827.1</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23690" xml_f="23704" txt_i="12877" txt_f="12891">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="23761" xml_f="23786" txt_i="12892" txt_f="12917">5' -ACCGCCGCAATGCCGCTGACT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="23844" xml_f="23898" txt_i="12918" txt_f="12972">Recycling of retinol binding protein—retinol complex [</offsets><xref rid="pone.0145924.ref009" ref-type="bibr"><offsets xml_i="23946" xml_f="23947" txt_i="12972" txt_f="12973">9</offsets></xref><offsets xml_i="23954" xml_f="23955" txt_i="12973" txt_f="12974">,</offsets><xref rid="pone.0145924.ref010" ref-type="bibr"><offsets xml_i="24003" xml_f="24005" txt_i="12974" txt_f="12976">10</offsets></xref><offsets xml_i="24012" xml_f="24013" txt_i="12976" txt_f="12977">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24114" xml_f="24128" txt_i="12979" txt_f="12993">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="24185" xml_f="24212" txt_i="12994" txt_f="13021">5' -TGCCCCAATGCCATAGGTAACGA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24331" xml_f="24360" txt_i="13023" txt_f="13052">Stimulated by retinoic acid 6</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24413" xml_f="24428" txt_i="13053" txt_f="13068">NM_0010029924.1</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="24581" xml_f="24588" txt_i="13071" txt_f="13078">(STRA6)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24641" xml_f="24655" txt_i="13079" txt_f="13093">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="24712" xml_f="24736" txt_i="13094" txt_f="13118">5' -CCGATCCTGGACAGTTCCTA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24794" xml_f="24833" txt_i="13119" txt_f="13158">Cellular uptake and efflux of retinol [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="24881" xml_f="24883" txt_i="13158" txt_f="13160">13</offsets></xref><offsets xml_i="24890" xml_f="24891" txt_i="13160" txt_f="13161">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="24992" xml_f="25006" txt_i="13163" txt_f="13177">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="25063" xml_f="25087" txt_i="13178" txt_f="13202">5' -CCACCTGGTAAGTGGCTGTT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25206" xml_f="25231" txt_i="13204" txt_f="13229">Retinol-binding protein 4</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25284" xml_f="25295" txt_i="13230" txt_f="13241">NM_013162.1</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="25448" xml_f="25454" txt_i="13244" txt_f="13250">(RBP4)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25507" xml_f="25521" txt_i="13251" txt_f="13265">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="25578" xml_f="25601" txt_i="13266" txt_f="13289">5’-CTGTGGACGAGAAGGGTCAT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25659" xml_f="25700" txt_i="13290" txt_f="13331">Retinol trafficking through circulation [</offsets><xref rid="pone.0145924.ref021" ref-type="bibr"><offsets xml_i="25748" xml_f="25750" txt_i="13331" txt_f="13333">21</offsets></xref><offsets xml_i="25757" xml_f="25758" txt_i="13333" txt_f="13334">,</offsets><xref rid="pone.0145924.ref022" ref-type="bibr"><offsets xml_i="25806" xml_f="25808" txt_i="13334" txt_f="13336">22</offsets></xref><offsets xml_i="25815" xml_f="25816" txt_i="13336" txt_f="13337">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="25917" xml_f="25931" txt_i="13339" txt_f="13353">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="25988" xml_f="26011" txt_i="13354" txt_f="13377">5’-GGAATACTGCAGAGCGAAGG</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="26130" xml_f="26153" txt_i="13379" txt_f="13402">Retinal dehydrogenase 1</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26206" xml_f="26217" txt_i="13403" txt_f="13414">NM_022407.3</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="26370" xml_f="26379" txt_i="13417" txt_f="13426">(RALDH-1)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26432" xml_f="26446" txt_i="13427" txt_f="13441">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="26503" xml_f="26527" txt_i="13442" txt_f="13466">5' -AATCAAGGAAGCTGCAGGAA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26585" xml_f="26640" txt_i="13467" txt_f="13522">Catalyzes oxidation of retinaldehyde to retinoic acid [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="26688" xml_f="26690" txt_i="13522" txt_f="13524">13</offsets></xref><offsets xml_i="26697" xml_f="26699" txt_i="13524" txt_f="13526">, </offsets><xref rid="pone.0145924.ref017" ref-type="bibr"><offsets xml_i="26747" xml_f="26749" txt_i="13526" txt_f="13528">17</offsets></xref><offsets xml_i="26756" xml_f="26757" txt_i="13528" txt_f="13529">,</offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="26805" xml_f="26807" txt_i="13529" txt_f="13531">24</offsets></xref><offsets xml_i="26814" xml_f="26815" txt_i="13531" txt_f="13532">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="26916" xml_f="26930" txt_i="13534" txt_f="13548">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="26987" xml_f="27011" txt_i="13549" txt_f="13573">5' -CACCCAGTTCTCGTCCATTT</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="27130" xml_f="27153" txt_i="13575" txt_f="13598">Retinal dehydrogenase 2</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27206" xml_f="27217" txt_i="13599" txt_f="13610">NM_053896.2</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="27370" xml_f="27379" txt_i="13613" txt_f="13622">(RALDH-2)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27432" xml_f="27446" txt_i="13623" txt_f="13637">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="27503" xml_f="27527" txt_i="13638" txt_f="13662">5' -AGAAGGATGGACGCTTCTGA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27585" xml_f="27640" txt_i="13663" txt_f="13718">Catalyzes oxidation of retinaldehyde to retinoic acid [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="27688" xml_f="27690" txt_i="13718" txt_f="13720">13</offsets></xref><offsets xml_i="27697" xml_f="27699" txt_i="13720" txt_f="13722">, </offsets><xref rid="pone.0145924.ref017" ref-type="bibr"><offsets xml_i="27747" xml_f="27749" txt_i="13722" txt_f="13724">17</offsets></xref><offsets xml_i="27756" xml_f="27757" txt_i="13724" txt_f="13725">,</offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="27805" xml_f="27807" txt_i="13725" txt_f="13727">24</offsets></xref><offsets xml_i="27814" xml_f="27815" txt_i="13727" txt_f="13728">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="27916" xml_f="27930" txt_i="13730" txt_f="13744">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="27987" xml_f="28011" txt_i="13745" txt_f="13769">5' -GTCCAAGTCAGCATCTGCAA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="28130" xml_f="28153" txt_i="13771" txt_f="13794">Retinal dehydrogenase 3</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28206" xml_f="28217" txt_i="13795" txt_f="13806">NM_153300.1</offsets></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="28370" xml_f="28379" txt_i="13809" txt_f="13818">(RALDH-3)</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28432" xml_f="28446" txt_i="13819" txt_f="13833">Forward primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="28503" xml_f="28527" txt_i="13834" txt_f="13858">5' -CGACCTGGAGGGCTGTATTA</offsets></monospace></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28585" xml_f="28640" txt_i="13859" txt_f="13914">Catalyzes oxidation of retinaldehyde to retinoic acid [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="28688" xml_f="28690" txt_i="13914" txt_f="13916">13</offsets></xref><offsets xml_i="28697" xml_f="28699" txt_i="13916" txt_f="13918">, </offsets><xref rid="pone.0145924.ref017" ref-type="bibr"><offsets xml_i="28747" xml_f="28749" txt_i="13918" txt_f="13920">17</offsets></xref><offsets xml_i="28756" xml_f="28757" txt_i="13920" txt_f="13921">,</offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="28805" xml_f="28807" txt_i="13921" txt_f="13923">24</offsets></xref><offsets xml_i="28814" xml_f="28815" txt_i="13923" txt_f="13924">]</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="28916" xml_f="28930" txt_i="13926" txt_f="13940">Reverse primer</offsets></td><td align="left" rowspan="1" colspan="1"><monospace><offsets xml_i="28987" xml_f="29011" txt_i="13941" txt_f="13965">5' -CTCTTCTTGGCGAACTCCAC</offsets></monospace></td><td align="left" rowspan="1" colspan="1"></td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec008"><title><offsets xml_i="29153" xml_f="29173" txt_i="13968" txt_f="13988">Statistical analysis</offsets></title><p><offsets xml_i="29184" xml_f="29602" txt_i="13989" txt_f="14407">Statistical analyses were conducted using Prism 6.0 software (GraphPad). Data are presented as group means ± SEM. Age-related differences in retinol content in plasma, liver, and lungs and gene expression in lungs, liver, and kidneys were tested by one-factor ANOVA with Holm-Sidak multiple comparisons post-hoc test followed by a linear trend test. Two-factor ANOVA with Holm-Sidak multiple comparisons and Student’s </offsets><italic><offsets xml_i="29610" xml_f="29611" txt_i="14407" txt_f="14408">t</offsets></italic><offsets xml_i="29620" xml_f="29781" txt_i="14408" txt_f="14569">-test were used to analyze the overall effects of oral treatments and the statistical difference between VARA versus placebo at each age. In addition, Student’s </offsets><italic><offsets xml_i="29789" xml_f="29790" txt_i="14569" txt_f="14570">t</offsets></italic><offsets xml_i="29799" xml_f="30211" txt_i="14570" txt_f="14982">-test was used analyzing gender difference in plasma retinol concentration and gene expression in tissues of VARA adult carry over group. For comparisons of all analyses, data was normalized to the mean mRNA value of the control group (P1 oil) set at 1.00, and the mean values of the other groups were converted accordingly to determine fold change. When variance terms were unequal, values were subjected to log</offsets><sub><offsets xml_i="30216" xml_f="30218" txt_i="14982" txt_f="14984">10</offsets></sub><offsets xml_i="30224" xml_f="30399" txt_i="14984" txt_f="15159"> transformation prior to statistical analysis. To account for outliers, Rout test to detect multiple outliers based on the statistical variation of the data. Differences with </offsets><italic><offsets xml_i="30407" xml_f="30408" txt_i="15159" txt_f="15160">P</offsets></italic><offsets xml_i="30417" xml_f="30456" txt_i="15160" txt_f="15196"> &lt; 0.05 were considered significant.</offsets></p></sec></sec><sec sec-type="results" id="sec009"><title><offsets xml_i="30515" xml_f="30522" txt_i="15199" txt_f="15206">Results</offsets></title><sec id="sec010"><title><offsets xml_i="30554" xml_f="30645" txt_i="15207" txt_f="15298">VARA supplementation increased total retinol in plasma, lung and liver of rats fed VAM diet</offsets></title><p><offsets xml_i="30656" xml_f="30911" txt_i="15299" txt_f="15554">Our studies assessed the ontogenic trajectory of VA stores and retinoid homeostatic gene expression in the control group in the absence of VARA supplementation, and the response of plasma, liver, lung and kidney to VARA, given at the times illustrated in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="30956" xml_f="30962" txt_i="15554" txt_f="15560">Fig 1A</offsets></xref><offsets xml_i="30969" xml_f="31145" txt_i="15560" txt_f="15736">. VARA doses were given at each time, marked with X, so that, for example, P10 neonates received doses at P1, P4, and P10, with the last dose 6 h before tissues were collected.</offsets></p><p><offsets xml_i="31152" xml_f="31276" txt_i="15737" txt_f="15861">In the absence of VARA supplementation, the plasma retinol of neonatal rats and dams fed VAM diet ranged from 0.6–1 μmol/L (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="31321" xml_f="31327" txt_i="15861" txt_f="15867">Fig 1B</offsets></xref><offsets xml_i="31334" xml_f="31447" txt_i="15867" txt_f="15980">; black bars). These values are consistent with previous results for VA-marginal or deficient human populations [</offsets><xref rid="pone.0145924.ref011" ref-type="bibr"><offsets xml_i="31495" xml_f="31497" txt_i="15980" txt_f="15982">11</offsets></xref><offsets xml_i="31504" xml_f="31565" txt_i="15982" txt_f="16043">], and in controlled feeding studies in VA-marginal animals [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="31613" xml_f="31614" txt_i="16043" txt_f="16044">3</offsets></xref><offsets xml_i="31621" xml_f="31623" txt_i="16044" txt_f="16046">, </offsets><xref rid="pone.0145924.ref016" ref-type="bibr"><offsets xml_i="31671" xml_f="31673" txt_i="16046" txt_f="16048">16</offsets></xref><offsets xml_i="31680" xml_f="31682" txt_i="16048" txt_f="16050">, </offsets><xref rid="pone.0145924.ref017" ref-type="bibr"><offsets xml_i="31730" xml_f="31732" txt_i="16050" txt_f="16052">17</offsets></xref><offsets xml_i="31739" xml_f="31814" txt_i="16052" txt_f="16127">]. Under this condition, VA concentrations in major storage organs, liver (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="31859" xml_f="31865" txt_i="16127" txt_f="16133">Fig 1C</offsets></xref><offsets xml_i="31872" xml_f="31884" txt_i="16133" txt_f="16145">) and lung (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="31929" xml_f="31935" txt_i="16145" txt_f="16151">Fig 1D</offsets></xref><offsets xml_i="31942" xml_f="32173" txt_i="16151" txt_f="16379">), equaled 50–70 nmol/g and &lt;10 nmol/g, respectively. During neonatal ontogeny, plasma and liver retinol concentrations did not differ significantly, but plasma and lung retinol levels were higher in adults compared to neonates.</offsets></p><p><offsets xml_i="32180" xml_f="32267" txt_i="16380" txt_f="16467">VARA supplementation resulted in a significant increase in plasma retinol at all ages (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="32312" xml_f="32318" txt_i="16467" txt_f="16473">Fig 1B</offsets></xref><offsets xml_i="32325" xml_f="32473" txt_i="16473" txt_f="16621">, blue bars). Adults that had been treated with VARA only as neonates (carry over group, red bars) did not differ from adults treated only with oil.</offsets></p><p></p><p><offsets xml_i="32487" xml_f="32646" txt_i="16623" txt_f="16782">For lung, total retinol concentrations were lower in neonates than in oil-treated adults, and concentrations increased after VARA supplementation at each age (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="32691" xml_f="32697" txt_i="16782" txt_f="16788">Fig 1D</offsets></xref><offsets xml_i="32704" xml_f="32801" txt_i="16788" txt_f="16885">; blue bars). There was no significant carry over effect of neonatal VARA treatment at adult age.</offsets></p><p><offsets xml_i="32808" xml_f="33025" txt_i="16886" txt_f="17097">Thus, plasma, liver and lung all responded significantly to VARA treatment (liver &gt; lung &gt; plasma). VARA supplementation of neonates without further treatment at adult age increased VA storage only in the liver.</offsets></p></sec><sec id="sec011"><title><offsets xml_i="33059" xml_f="33175" txt_i="17099" txt_f="17215">Retinoid homeostatic gene expression is differentially regulated in neonatal and adult liver by VARA supplementation</offsets></title><p><offsets xml_i="33186" xml_f="33251" txt_i="17216" txt_f="17281">The level of transcripts for several retinoid homeostatic genes (</offsets><xref rid="pone.0145924.t001" ref-type="table"><offsets xml_i="33298" xml_f="33305" txt_i="17281" txt_f="17288">Table 1</offsets></xref><offsets xml_i="33312" xml_f="33318" txt_i="17288" txt_f="17294"> and [</offsets><xref rid="pone.0145924.ref009" ref-type="bibr"><offsets xml_i="33366" xml_f="33367" txt_i="17294" txt_f="17295">9</offsets></xref><offsets xml_i="33374" xml_f="33376" txt_i="17295" txt_f="17297">, </offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="33424" xml_f="33426" txt_i="17297" txt_f="17299">13</offsets></xref><offsets xml_i="33433" xml_f="33435" txt_i="17299" txt_f="17301">, </offsets><xref rid="pone.0145924.ref018" ref-type="bibr"><offsets xml_i="33483" xml_f="33485" txt_i="17301" txt_f="17303">18</offsets></xref><offsets xml_i="33492" xml_f="33493" txt_i="17303" txt_f="17304">–</offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="33541" xml_f="33543" txt_i="17304" txt_f="17306">24</offsets></xref><offsets xml_i="33550" xml_f="33683" txt_i="17306" txt_f="17439">] were quantified by qRT-PCR in the liver of rats during normal ontogeny (oil group) and after VARA supplementation, as described in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="33728" xml_f="33734" txt_i="17439" txt_f="17445">Fig 1A</offsets></xref><offsets xml_i="33741" xml_f="33800" txt_i="17445" txt_f="17504">. For liver, these genes included retinol-binding protein (</offsets><italic><offsets xml_i="33808" xml_f="33813" txt_i="17504" txt_f="17509">Rbp)4</offsets></italic><offsets xml_i="33822" xml_f="33930" txt_i="17509" txt_f="17617">, responsible for the release of retinol from liver into the circulation; lecithin:retinol acyltransferase (</offsets><italic><offsets xml_i="33938" xml_f="33942" txt_i="17617" txt_f="17621">Lrat</offsets></italic><offsets xml_i="33951" xml_f="34033" txt_i="17621" txt_f="17703">), responsible for VA storage as retinyl esters; and cytochrome P450, family 26, (</offsets><italic><offsets xml_i="34041" xml_f="34047" txt_i="17703" txt_f="17709">Cyp26)</offsets></italic><offsets xml_i="34056" xml_f="34070" txt_i="17709" txt_f="17723"> subfamily A (</offsets><italic><offsets xml_i="34078" xml_f="34080" txt_i="17723" txt_f="17725">A1</offsets></italic><offsets xml_i="34089" xml_f="34140" txt_i="17725" txt_f="17776">), responsible for the oxidation of retinoic acid (</offsets><xref rid="pone.0145924.t001" ref-type="table"><offsets xml_i="34187" xml_f="34194" txt_i="17776" txt_f="17783">Table 1</offsets></xref><offsets xml_i="34201" xml_f="34203" txt_i="17783" txt_f="17785">).</offsets></p><p><italic><offsets xml_i="34218" xml_f="34222" txt_i="17786" txt_f="17790">Rbp4</offsets></italic><offsets xml_i="34231" xml_f="34284" txt_i="17790" txt_f="17843"> transcripts increased with age in oil-treated rats (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="34329" xml_f="34335" txt_i="17843" txt_f="17849">Fig 2A</offsets></xref><offsets xml_i="34342" xml_f="34419" txt_i="17849" txt_f="17926">, black bars) with a significant difference between neonatal and adult ages (</offsets><italic><offsets xml_i="34427" xml_f="34428" txt_i="17926" txt_f="17927">P</offsets></italic><offsets xml_i="34437" xml_f="34493" txt_i="17927" txt_f="17980"> &lt; 0.05). VARA supplementation significantly reduced </offsets><italic><offsets xml_i="34501" xml_f="34505" txt_i="17980" txt_f="17984">Rbp4</offsets></italic><offsets xml_i="34514" xml_f="34542" txt_i="17984" txt_f="18012"> mRNA at each neonatal age (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="34587" xml_f="34593" txt_i="18012" txt_f="18018">Fig 2A</offsets></xref><offsets xml_i="34600" xml_f="34617" txt_i="18018" txt_f="18035">, blue bars, all </offsets><italic><offsets xml_i="34625" xml_f="34626" txt_i="18035" txt_f="18036">P</offsets></italic><offsets xml_i="34635" xml_f="34687" txt_i="18036" txt_f="18085"> &lt; 0.05). By adult age compared to neonatal age, </offsets><italic><offsets xml_i="34695" xml_f="34699" txt_i="18085" txt_f="18089">Rbp4</offsets></italic><offsets xml_i="34708" xml_f="34808" txt_i="18089" txt_f="18189"> mRNA was higher for both oil and VARA groups. Additionally, we observed a significant reduction in </offsets><italic><offsets xml_i="34816" xml_f="34820" txt_i="18189" txt_f="18193">Rbp4</offsets></italic><offsets xml_i="34829" xml_f="34912" txt_i="18193" txt_f="18276"> mRNA in adult rats that had been treated with VARA as neonates, but not as adults.</offsets></p><fig id="pone.0145924.g002" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="35013" xml_f="35046" txt_i="18277" txt_f="18310">10.1371/journal.pone.0145924.g002</offsets></object-id><label><offsets xml_i="35065" xml_f="35070" txt_i="18310" txt_f="18315">Fig 2</offsets></label><caption><title><offsets xml_i="35094" xml_f="35227" txt_i="18315" txt_f="18448">Expression of retinoid homeostatic genes in liver of neonatal rats and adult-age rats fed VAM diet supplemented with or without VARA.</offsets></title><p><offsets xml_i="35238" xml_f="35278" txt_i="18449" txt_f="18489">Relative levels of mRNA transcripts for </offsets><italic><offsets xml_i="35286" xml_f="35290" txt_i="18489" txt_f="18493">Rbp4</offsets></italic><offsets xml_i="35299" xml_f="35305" txt_i="18493" txt_f="18499"> (A), </offsets><italic><offsets xml_i="35313" xml_f="35317" txt_i="18499" txt_f="18503">Lrat</offsets></italic><offsets xml_i="35326" xml_f="35336" txt_i="18503" txt_f="18513"> (B), and </offsets><italic><offsets xml_i="35344" xml_f="35351" txt_i="18513" txt_f="18520">Cyp26a1</offsets></italic><offsets xml_i="35360" xml_f="35429" txt_i="18520" txt_f="18589"> (C) are shown for liver, under experimental conditions described in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="35474" xml_f="35480" txt_i="18589" txt_f="18595">Fig 1A</offsets></xref><offsets xml_i="35487" xml_f="35572" txt_i="18595" txt_f="18680">. Developmental expression patterns in the control group are shown by black bars for </offsets><italic><offsets xml_i="35580" xml_f="35584" txt_i="18680" txt_f="18684">Rbp4</offsets></italic><offsets xml_i="35593" xml_f="35599" txt_i="18684" txt_f="18690"> (A), </offsets><italic><offsets xml_i="35607" xml_f="35611" txt_i="18690" txt_f="18694">Lrat</offsets></italic><offsets xml_i="35620" xml_f="35630" txt_i="18694" txt_f="18704"> (B), and </offsets><italic><offsets xml_i="35638" xml_f="35645" txt_i="18704" txt_f="18711">Cyp26A1</offsets></italic><offsets xml_i="35654" xml_f="35837" txt_i="18711" txt_f="18894"> (C) and levels after VARA in blue bars. The group labeled “VARA Carryover” (red bars) received VARA on P1, P4, P7, and P10 as neonates, but were not treated with VARA as adults (see </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="35882" xml_f="35888" txt_i="18894" txt_f="18900">Fig 1A</offsets></xref><offsets xml_i="35895" xml_f="36335" txt_i="18900" txt_f="19340">). For comparison of relative values, the average value for the control group (P1, oil) was set to 1.00 for each assay and fold change for each gene is shown as relative to this value. Data are shown as mean ± SEM, n ≥ 5/group. One-way ANOVA with post-hoc analysis was used to determine differences between oil-treated groups at different ages, indicative of differences due to ontogeny. Means without a common letter differ significantly, </offsets><italic><offsets xml_i="36343" xml_f="36344" txt_i="19340" txt_f="19341">P</offsets></italic><offsets xml_i="36353" xml_f="36419" txt_i="19341" txt_f="19404"> &lt; 0.05. For each age, VARA versus Oil groups were compared by </offsets><italic><offsets xml_i="36427" xml_f="36428" txt_i="19404" txt_f="19405">t</offsets></italic><offsets xml_i="36437" xml_f="36456" txt_i="19405" txt_f="19424">-test; * indicates </offsets><italic><offsets xml_i="36464" xml_f="36465" txt_i="19424" txt_f="19425">P</offsets></italic><offsets xml_i="36474" xml_f="36568" txt_i="19425" txt_f="19516"> &lt; 0.05. Abbreviations: P, postnatal day; VARA, vitamin A combined with 10% retinoic acid; </offsets><italic><offsets xml_i="36576" xml_f="36580" txt_i="19516" txt_f="19520">Rbp4</offsets></italic><offsets xml_i="36589" xml_f="36618" txt_i="19520" txt_f="19549">, retinol-binding protein 4; </offsets><italic><offsets xml_i="36626" xml_f="36630" txt_i="19549" txt_f="19553">Lrat</offsets></italic><offsets xml_i="36639" xml_f="36675" txt_i="19553" txt_f="19589">, lecithin:retinol acyltransferase; </offsets><italic><offsets xml_i="36683" xml_f="36690" txt_i="19589" txt_f="19596">Cyp26A1</offsets></italic><offsets xml_i="36699" xml_f="36753" txt_i="19596" txt_f="19650">, cytochrome P450 family 26 subfamily c polypeptide 1.</offsets></p></caption><graphic xlink:href="pone.0145924.g002"></graphic></fig><p><italic><offsets xml_i="36834" xml_f="36838" txt_i="19651" txt_f="19655">Lrat</offsets></italic><offsets xml_i="36847" xml_f="36900" txt_i="19655" txt_f="19708"> transcripts increased with age in oil-treated rats (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="36945" xml_f="36951" txt_i="19708" txt_f="19714">Fig 2B</offsets></xref><offsets xml_i="36958" xml_f="37036" txt_i="19714" txt_f="19792">, black bars), with a significant difference between neonatal and adult ages (</offsets><italic><offsets xml_i="37044" xml_f="37045" txt_i="19792" txt_f="19793">P</offsets></italic><offsets xml_i="37054" xml_f="37089" txt_i="19793" txt_f="19825"> &lt; 0.05). VARA supplementation (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="37134" xml_f="37140" txt_i="19825" txt_f="19831">Fig 2B</offsets></xref><offsets xml_i="37147" xml_f="37170" txt_i="19831" txt_f="19854">, blue bars) increased </offsets><italic><offsets xml_i="37178" xml_f="37182" txt_i="19854" txt_f="19858">Lrat</offsets></italic><offsets xml_i="37191" xml_f="37381" txt_i="19858" txt_f="20048"> transcript level on average at all ages, which was statistically significant for P4 and adult rats. Adult rats that had been treated with VARA as neonates had significantly lower levels of </offsets><italic><offsets xml_i="37389" xml_f="37393" txt_i="20048" txt_f="20052">Lrat</offsets></italic><offsets xml_i="37402" xml_f="37415" txt_i="20052" txt_f="20065"> expression (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="37460" xml_f="37466" txt_i="20065" txt_f="20071">Fig 2B</offsets></xref><offsets xml_i="37473" xml_f="37555" txt_i="20071" txt_f="20153">, red bar) compared both to oil-treated controls and VARA-supplemented adult rats.</offsets></p><p><italic><offsets xml_i="37570" xml_f="37577" txt_i="20154" txt_f="20161">Cyp26A1</offsets></italic><offsets xml_i="37586" xml_f="37648" txt_i="20161" txt_f="20223"> transcripts increased slightly with age in oil-treated rats (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="37693" xml_f="37699" txt_i="20223" txt_f="20229">Fig 2C</offsets></xref><offsets xml_i="37706" xml_f="37782" txt_i="20229" txt_f="20305">, black bars), with a significant increase in adults. VARA supplementation (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="37827" xml_f="37833" txt_i="20305" txt_f="20311">Fig 2C</offsets></xref><offsets xml_i="37840" xml_f="37863" txt_i="20311" txt_f="20334">, blue bars) increased </offsets><italic><offsets xml_i="37871" xml_f="37876" txt_i="20334" txt_f="20339">Cyp26</offsets></italic><offsets xml_i="37885" xml_f="38014" txt_i="20339" txt_f="20468"> transcript level on average at all ages, which was statistically significant for P10 and adult rats. By adult age, VARA induced </offsets><italic><offsets xml_i="38022" xml_f="38029" txt_i="20468" txt_f="20475">Cyp26A1</offsets></italic><offsets xml_i="38038" xml_f="38173" txt_i="20475" txt_f="20610"> expression to a much greater degree than was observed in neonates. There was no carry over effect of neonatal VARA supplementation on </offsets><italic><offsets xml_i="38181" xml_f="38188" txt_i="20610" txt_f="20617">Cyp26A1</offsets></italic><offsets xml_i="38197" xml_f="38231" txt_i="20617" txt_f="20651"> expression levels in adult liver.</offsets></p><p><offsets xml_i="38238" xml_f="38317" txt_i="20652" txt_f="20731">Thus, for liver, VARA supplementation of neonates attenuated the expression of </offsets><italic><offsets xml_i="38325" xml_f="38329" txt_i="20731" txt_f="20735">Rbp4</offsets></italic><offsets xml_i="38338" xml_f="38362" txt_i="20735" txt_f="20759"> in liver at adult age. </offsets><italic><offsets xml_i="38370" xml_f="38374" txt_i="20759" txt_f="20763">Lrat</offsets></italic><offsets xml_i="38383" xml_f="38388" txt_i="20763" txt_f="20768"> and </offsets><italic><offsets xml_i="38396" xml_f="38403" txt_i="20768" txt_f="20775">Cyp26A1</offsets></italic><offsets xml_i="38412" xml_f="38614" txt_i="20775" txt_f="20977"> responded to VARA supplementation more strongly in adult rat liver, compared to in neonates; however, neither of these genes exhibited a carry over effect of neonatal VARA supplementation at adult age.</offsets></p></sec><sec id="sec012"><title><offsets xml_i="38648" xml_f="38731" txt_i="20979" txt_f="21062">VARA supplementation increased expression of retinoid homeostatic genes in rat lung</offsets></title><p><offsets xml_i="38742" xml_f="38793" txt_i="21063" txt_f="21114">The transcripts for Stimulated by retinoic acid 6 (</offsets><italic><offsets xml_i="38801" xml_f="38806" txt_i="21114" txt_f="21119">Stra6</offsets></italic><offsets xml_i="38815" xml_f="38818" txt_i="21119" txt_f="21122">), </offsets><italic><offsets xml_i="38826" xml_f="38830" txt_i="21122" txt_f="21126">Lrat</offsets></italic><offsets xml_i="38839" xml_f="38845" txt_i="21126" txt_f="21132">, and </offsets><italic><offsets xml_i="38853" xml_f="38858" txt_i="21132" txt_f="21137">CYP26</offsets></italic><offsets xml_i="38867" xml_f="38882" txt_i="21137" txt_f="21152">, subfamily B (</offsets><italic><offsets xml_i="38890" xml_f="38898" txt_i="21152" txt_f="21160">Cyp26B1)</offsets></italic><offsets xml_i="38907" xml_f="38909" txt_i="21160" txt_f="21162"> (</offsets><xref rid="pone.0145924.t001" ref-type="table"><offsets xml_i="38956" xml_f="38963" txt_i="21162" txt_f="21169">Table 1</offsets></xref><offsets xml_i="38970" xml_f="39105" txt_i="21169" txt_f="21304">), were determined by qPCR in lung tissue from rats during postnatal development, without and with VARA supplementation, and in adults.</offsets></p><p><offsets xml_i="39112" xml_f="39116" txt_i="21305" txt_f="21309">For </offsets><italic><offsets xml_i="39124" xml_f="39129" txt_i="21309" txt_f="21314">Stra6</offsets></italic><offsets xml_i="39138" xml_f="39207" txt_i="21314" txt_f="21383">, transcript levels were similar in oil-treated animals at each age (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="39252" xml_f="39258" txt_i="21383" txt_f="21389">Fig 3A</offsets></xref><offsets xml_i="39265" xml_f="39399" txt_i="21389" txt_f="21523">; black bars), indicating no developmental pattern. After VARA supplementation, Stra6 expression increased significantly at each age (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="39444" xml_f="39450" txt_i="21523" txt_f="21529">Fig 3A</offsets></xref><offsets xml_i="39457" xml_f="39541" txt_i="21529" txt_f="21613">; blue bars); however, the magnitude of increase decreased negative trend with age (</offsets><italic><offsets xml_i="39549" xml_f="39550" txt_i="21613" txt_f="21614">P</offsets></italic><offsets xml_i="39559" xml_f="39663" txt_i="21614" txt_f="21715"> &lt; 0.0001 for VARA). There was no carry over effect of neonatal-age VARA treatment in the adult lung.</offsets></p><fig id="pone.0145924.g003" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="39764" xml_f="39797" txt_i="21716" txt_f="21749">10.1371/journal.pone.0145924.g003</offsets></object-id><label><offsets xml_i="39816" xml_f="39821" txt_i="21749" txt_f="21754">Fig 3</offsets></label><caption><title><offsets xml_i="39845" xml_f="39978" txt_i="21754" txt_f="21887">Expression of retinoid homeostatic genes in lungs of neonatal rats and adult-age rats fed VAM diet supplemented with or without VARA.</offsets></title><p><offsets xml_i="39989" xml_f="40039" txt_i="21888" txt_f="21938">Relative levels of mRNA transcripts are shown for </offsets><italic><offsets xml_i="40047" xml_f="40052" txt_i="21938" txt_f="21943">Stra6</offsets></italic><offsets xml_i="40061" xml_f="40067" txt_i="21943" txt_f="21949"> (A), </offsets><italic><offsets xml_i="40075" xml_f="40079" txt_i="21949" txt_f="21953">Lrat</offsets></italic><offsets xml_i="40088" xml_f="40098" txt_i="21953" txt_f="21963"> (B), and </offsets><italic><offsets xml_i="40106" xml_f="40113" txt_i="21963" txt_f="21970">Cyp26B1</offsets></italic><offsets xml_i="40122" xml_f="40178" txt_i="21970" txt_f="22026"> (C) in lung under experimental conditions described in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="40223" xml_f="40229" txt_i="22026" txt_f="22032">Fig 1A</offsets></xref><offsets xml_i="40236" xml_f="40493" txt_i="22032" txt_f="22289">. Data are shown as mean ± SEM, n ≥ 5/group. One-way ANOVA with post-hoc analysis was used to determine differences between oil-treated groups at different ages, indicative of differences due to ontogeny. Means without a common letter differ significantly, </offsets><italic><offsets xml_i="40501" xml_f="40502" txt_i="22289" txt_f="22290">P</offsets></italic><offsets xml_i="40511" xml_f="40577" txt_i="22290" txt_f="22353"> &lt; 0.05. For each age, VARA versus Oil groups were compared by </offsets><italic><offsets xml_i="40585" xml_f="40586" txt_i="22353" txt_f="22354">t</offsets></italic><offsets xml_i="40595" xml_f="40614" txt_i="22354" txt_f="22373">-test; * indicates </offsets><italic><offsets xml_i="40622" xml_f="40623" txt_i="22373" txt_f="22374">P</offsets></italic><offsets xml_i="40632" xml_f="40726" txt_i="22374" txt_f="22465"> &lt; 0.05. Abbreviations: P, postnatal day; VARA, vitamin A combined with 10% retinoic acid; </offsets><italic><offsets xml_i="40734" xml_f="40739" txt_i="22465" txt_f="22470">Stra6</offsets></italic><offsets xml_i="40748" xml_f="40784" txt_i="22470" txt_f="22506">, Stimulated by retinoic acid gene 6</offsets><italic><offsets xml_i="40792" xml_f="40798" txt_i="22506" txt_f="22512">; Rbp4</offsets></italic><offsets xml_i="40807" xml_f="40836" txt_i="22512" txt_f="22541">, retinol-binding protein 4; </offsets><italic><offsets xml_i="40844" xml_f="40848" txt_i="22541" txt_f="22545">Lrat</offsets></italic><offsets xml_i="40857" xml_f="40893" txt_i="22545" txt_f="22581">, lecithin:retinol acyltransferase; </offsets><italic><offsets xml_i="40901" xml_f="40908" txt_i="22581" txt_f="22588">Cyp26B1</offsets></italic><offsets xml_i="40917" xml_f="40971" txt_i="22588" txt_f="22642">, cytochrome P450 family 26 subfamily b polypeptide 1.</offsets></p></caption><graphic xlink:href="pone.0145924.g003"></graphic></fig><p><offsets xml_i="41044" xml_f="41048" txt_i="22643" txt_f="22647">For </offsets><italic><offsets xml_i="41056" xml_f="41060" txt_i="22647" txt_f="22651">Lrat</offsets></italic><offsets xml_i="41069" xml_f="41138" txt_i="22651" txt_f="22720">, there was a significant age-related trend in the oil-treated rats (</offsets><italic><offsets xml_i="41146" xml_f="41147" txt_i="22720" txt_f="22721">P</offsets></italic><offsets xml_i="41156" xml_f="41217" txt_i="22721" txt_f="22779"> &lt; 0.001), driven by higher expression in the adult lung (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="41262" xml_f="41268" txt_i="22779" txt_f="22785">Fig 3B</offsets></xref><offsets xml_i="41275" xml_f="41318" txt_i="22785" txt_f="22828">; black bars). After VARA supplementation, </offsets><italic><offsets xml_i="41326" xml_f="41330" txt_i="22828" txt_f="22832">Lrat</offsets></italic><offsets xml_i="41339" xml_f="41388" txt_i="22832" txt_f="22881"> expression increased significantly at each age (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="41433" xml_f="41439" txt_i="22881" txt_f="22887">Fig 3B</offsets></xref><offsets xml_i="41446" xml_f="41533" txt_i="22887" txt_f="22974">; blue bars). There was a significant effect of neonatal VARA supplementation on adult </offsets><italic><offsets xml_i="41541" xml_f="41545" txt_i="22974" txt_f="22978">Lrat</offsets></italic><offsets xml_i="41554" xml_f="41666" txt_i="22978" txt_f="23090"> transcript levels, which were significantly lower than in either the oil-treated or adult VARA-treated groups (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="41711" xml_f="41717" txt_i="23090" txt_f="23096">Fig 3B</offsets></xref><offsets xml_i="41724" xml_f="41736" txt_i="23096" txt_f="23108">, red bars, </offsets><italic><offsets xml_i="41744" xml_f="41745" txt_i="23108" txt_f="23109">P</offsets></italic><offsets xml_i="41754" xml_f="41766" txt_i="23109" txt_f="23118"> &lt; 0.05).</offsets></p><p><offsets xml_i="41773" xml_f="41782" txt_i="23119" txt_f="23128">Although </offsets><italic><offsets xml_i="41790" xml_f="41794" txt_i="23128" txt_f="23132">Cyps</offsets></italic><offsets xml_i="41803" xml_f="41842" txt_i="23132" txt_f="23171"> are generally expressed in the liver [</offsets><xref rid="pone.0145924.ref017" ref-type="bibr"><offsets xml_i="41890" xml_f="41892" txt_i="23171" txt_f="23173">17</offsets></xref><offsets xml_i="41899" xml_f="41901" txt_i="23173" txt_f="23175">, </offsets><xref rid="pone.0145924.ref023" ref-type="bibr"><offsets xml_i="41949" xml_f="41951" txt_i="23175" txt_f="23177">23</offsets></xref><offsets xml_i="41958" xml_f="41959" txt_i="23177" txt_f="23178">–</offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="42007" xml_f="42009" txt_i="23178" txt_f="23180">24</offsets></xref><offsets xml_i="42016" xml_f="42019" txt_i="23180" txt_f="23183">], </offsets><italic><offsets xml_i="42027" xml_f="42034" txt_i="23183" txt_f="23190">Cyp26A1</offsets></italic><offsets xml_i="42043" xml_f="42048" txt_i="23190" txt_f="23195"> and </offsets><italic><offsets xml_i="42056" xml_f="42063" txt_i="23195" txt_f="23202">Cyp26B1</offsets></italic><offsets xml_i="42072" xml_f="42116" txt_i="23202" txt_f="23246"> transcripts are expressed in lung tissues [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="42164" xml_f="42166" txt_i="23246" txt_f="23248">13</offsets></xref><offsets xml_i="42173" xml_f="42175" txt_i="23248" txt_f="23250">, </offsets><xref rid="pone.0145924.ref024" ref-type="bibr"><offsets xml_i="42223" xml_f="42225" txt_i="23250" txt_f="23252">24</offsets></xref><offsets xml_i="42232" xml_f="42244" txt_i="23252" txt_f="23264">]; however, </offsets><italic><offsets xml_i="42252" xml_f="42259" txt_i="23264" txt_f="23271">Cyp26B1</offsets></italic><offsets xml_i="42268" xml_f="42318" txt_i="23271" txt_f="23321"> is more highly expressed in the lung compared to </offsets><italic><offsets xml_i="42326" xml_f="42333" txt_i="23321" txt_f="23328">Cyp26A1</offsets></italic><offsets xml_i="42342" xml_f="42344" txt_i="23328" txt_f="23330"> [</offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="42392" xml_f="42394" txt_i="23330" txt_f="23332">13</offsets></xref><offsets xml_i="42401" xml_f="42404" txt_i="23332" txt_f="23335">]. </offsets><italic><offsets xml_i="42412" xml_f="42419" txt_i="23335" txt_f="23342">Cyp26B1</offsets></italic><offsets xml_i="42428" xml_f="42488" txt_i="23342" txt_f="23402"> transcripts were very low in oil-treated rats at each age (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="42533" xml_f="42539" txt_i="23402" txt_f="23408">Fig 3C</offsets></xref><offsets xml_i="42546" xml_f="42588" txt_i="23408" txt_f="23450">; black bars). After VARA supplementation </offsets><italic><offsets xml_i="42596" xml_f="42603" txt_i="23450" txt_f="23457">Cyp26B1</offsets></italic><offsets xml_i="42612" xml_f="42709" txt_i="23457" txt_f="23554"> expression increased strongly in neonatal lung, but the increase was not significant in adults (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="42754" xml_f="42760" txt_i="23554" txt_f="23560">Fig 3C</offsets></xref><offsets xml_i="42767" xml_f="42792" txt_i="23560" txt_f="23585">; blue bars). Similar to </offsets><italic><offsets xml_i="42800" xml_f="42804" txt_i="23585" txt_f="23589">Lrat</offsets></italic><offsets xml_i="42813" xml_f="42888" txt_i="23589" txt_f="23664">, there was a significant effect of neonatal VARA supplementation on adult </offsets><italic><offsets xml_i="42896" xml_f="42903" txt_i="23664" txt_f="23671">Cyp26B1</offsets></italic><offsets xml_i="42912" xml_f="43024" txt_i="23671" txt_f="23783"> transcript levels, which were significantly lower than in either the oil-treated or adult VARA-treated groups (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="43069" xml_f="43075" txt_i="23783" txt_f="23789">Fig 3C</offsets></xref><offsets xml_i="43082" xml_f="43094" txt_i="23789" txt_f="23801">, red bars, </offsets><italic><offsets xml_i="43102" xml_f="43103" txt_i="23801" txt_f="23802">P</offsets></italic><offsets xml_i="43112" xml_f="43124" txt_i="23802" txt_f="23811"> &lt; 0.05).</offsets></p></sec><sec id="sec013"><title><offsets xml_i="43158" xml_f="43274" txt_i="23813" txt_f="23929">Retinaldehyde dehydrogenases in lung exhibited distinct expression patterns during ontogeny and VARA supplementation</offsets></title><p><offsets xml_i="43285" xml_f="43346" txt_i="23930" txt_f="23991">The transcript levels for three retinaldehyde dehydrogenase (</offsets><italic><offsets xml_i="43354" xml_f="43359" txt_i="23991" txt_f="23996">Raldh</offsets></italic><offsets xml_i="43368" xml_f="43377" txt_i="23996" txt_f="24005">) genes, </offsets><italic><offsets xml_i="43385" xml_f="43392" txt_i="24005" txt_f="24012">Raldh-1</offsets></italic><offsets xml_i="43401" xml_f="43403" txt_i="24012" txt_f="24014">, </offsets><italic><offsets xml_i="43411" xml_f="43418" txt_i="24014" txt_f="24021">Raldh-2</offsets></italic><offsets xml_i="43427" xml_f="43433" txt_i="24021" txt_f="24027">, and </offsets><italic><offsets xml_i="43441" xml_f="43448" txt_i="24027" txt_f="24034">Raldh-3</offsets></italic><offsets xml_i="43457" xml_f="43605" txt_i="24034" txt_f="24182">, were determined by qPCR in neonatal and adult lung. Based on cycle threshold numbers, the relative expression levels among these three genes were </offsets><italic><offsets xml_i="43613" xml_f="43646" txt_i="24182" txt_f="24209">Raldh-1 &gt; Raldh-3 &gt; Raldh-2</offsets></italic><offsets xml_i="43655" xml_f="43657" txt_i="24209" txt_f="24211">. </offsets><italic><offsets xml_i="43665" xml_f="43672" txt_i="24211" txt_f="24218">Raldh-1</offsets></italic><offsets xml_i="43681" xml_f="43728" txt_i="24218" txt_f="24265"> expression displayed an age-related increase (</offsets><italic><offsets xml_i="43736" xml_f="43737" txt_i="24265" txt_f="24266">P</offsets></italic><offsets xml_i="43746" xml_f="43820" txt_i="24266" txt_f="24337"> &lt; 0.001) in the control group, driven by higher expression in adults (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="43865" xml_f="43871" txt_i="24337" txt_f="24343">Fig 4A</offsets></xref><offsets xml_i="43878" xml_f="43982" txt_i="24343" txt_f="24447">; black bars). VARA supplementation altered expression only in adults, in which expression was reduced (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="44027" xml_f="44033" txt_i="24447" txt_f="24453">Fig 4A</offsets></xref><offsets xml_i="44040" xml_f="44129" txt_i="24453" txt_f="24542">; blue bars). There was no carry over effect of neonatal VARA supplementation in adults (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="44174" xml_f="44180" txt_i="24542" txt_f="24548">Fig 4A</offsets></xref><offsets xml_i="44187" xml_f="44262" txt_i="24548" txt_f="24623">; red bars). VARA supplementation resulted in a significant suppression of </offsets><italic><offsets xml_i="44270" xml_f="44277" txt_i="24623" txt_f="24630">Raldh-2</offsets></italic><offsets xml_i="44286" xml_f="44309" txt_i="24630" txt_f="24653"> expression in adults (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="44354" xml_f="44360" txt_i="24653" txt_f="24659">Fig 4B</offsets></xref><offsets xml_i="44367" xml_f="44379" txt_i="24659" txt_f="24671">; red bar). </offsets><italic><offsets xml_i="44387" xml_f="44394" txt_i="24671" txt_f="24678">Raldh-3</offsets></italic><offsets xml_i="44403" xml_f="44458" txt_i="24678" txt_f="24733"> transcript levels were lower in neonates than adults (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="44503" xml_f="44509" txt_i="24733" txt_f="24739">Fig 4C</offsets></xref><offsets xml_i="44516" xml_f="44542" txt_i="24739" txt_f="24765">, black bars), resembling </offsets><italic><offsets xml_i="44550" xml_f="44557" txt_i="24765" txt_f="24772">Raldh-1</offsets></italic><offsets xml_i="44566" xml_f="44628" txt_i="24772" txt_f="24834"> in this respect. However, VARA supplementation did not alter </offsets><italic><offsets xml_i="44636" xml_f="44643" txt_i="24834" txt_f="24841">Raldh-3</offsets></italic><offsets xml_i="44652" xml_f="44702" txt_i="24841" txt_f="24891"> transcript levels at any of the ages we examined.</offsets></p><fig id="pone.0145924.g004" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="44803" xml_f="44836" txt_i="24892" txt_f="24925">10.1371/journal.pone.0145924.g004</offsets></object-id><label><offsets xml_i="44855" xml_f="44860" txt_i="24925" txt_f="24930">Fig 4</offsets></label><caption><title><offsets xml_i="44884" xml_f="45017" txt_i="24930" txt_f="25063">Expression of retinoid biosynthetic genes in lungs of neonatal rats and adult-age rats fed VAM diet and treated with or without VARA.</offsets></title><p><offsets xml_i="45028" xml_f="45078" txt_i="25064" txt_f="25114">Relative levels of mRNA transcripts are shown for </offsets><italic><offsets xml_i="45086" xml_f="45093" txt_i="25114" txt_f="25121">Raldh-1</offsets></italic><offsets xml_i="45102" xml_f="45124" txt_i="25121" txt_f="25143"> (A), Raldh-2 (B) and </offsets><italic><offsets xml_i="45132" xml_f="45139" txt_i="25143" txt_f="25150">Raldh-3</offsets></italic><offsets xml_i="45148" xml_f="45205" txt_i="25150" txt_f="25207"> (C) in lung, under experimental conditions described in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="45250" xml_f="45256" txt_i="25207" txt_f="25213">Fig 1A</offsets></xref><offsets xml_i="45263" xml_f="45520" txt_i="25213" txt_f="25470">. Data are shown as mean ± SEM, n ≥ 5/group. One-way ANOVA with post-hoc analysis was used to determine differences between oil-treated groups at different ages, indicative of differences due to ontogeny. Means without a common letter differ significantly, </offsets><italic><offsets xml_i="45528" xml_f="45529" txt_i="25470" txt_f="25471">P</offsets></italic><offsets xml_i="45538" xml_f="45604" txt_i="25471" txt_f="25534"> &lt; 0.05. For each age, VARA versus Oil groups were compared by </offsets><italic><offsets xml_i="45612" xml_f="45613" txt_i="25534" txt_f="25535">t</offsets></italic><offsets xml_i="45622" xml_f="45641" txt_i="25535" txt_f="25554">-test; * indicates </offsets><italic><offsets xml_i="45649" xml_f="45650" txt_i="25554" txt_f="25555">P</offsets></italic><offsets xml_i="45659" xml_f="45753" txt_i="25555" txt_f="25646"> &lt; 0.05. Abbreviations: P, postnatal day; VARA, vitamin A combined with 10% retinoic acid; </offsets><italic><offsets xml_i="45761" xml_f="45766" txt_i="25646" txt_f="25651">Raldh</offsets></italic><offsets xml_i="45775" xml_f="45805" txt_i="25651" txt_f="25681">, retinaldehyde dehydrogenase.</offsets></p></caption><graphic xlink:href="pone.0145924.g004"></graphic></fig></sec><sec id="sec014"><title><offsets xml_i="45905" xml_f="45984" txt_i="25683" txt_f="25762">Neonatal megalin expression in kidneys is not regulated by VARA supplementation</offsets></title><p><offsets xml_i="45995" xml_f="46029" txt_i="25763" txt_f="25797">The transcript level for megalin (</offsets><italic><offsets xml_i="46037" xml_f="46041" txt_i="25797" txt_f="25801">Lrp2</offsets></italic><offsets xml_i="46050" xml_f="46245" txt_i="25801" txt_f="25996">), responsible for reuptake of plasma retinol-RBP in proximal tubules, was determined in neonatal and adult kidney. There were no differences during ontogeny or after VARA treatment in neonates (</offsets><xref rid="pone.0145924.g005" ref-type="fig"><offsets xml_i="46290" xml_f="46296" txt_i="25996" txt_f="26002">Fig 5A</offsets></xref><offsets xml_i="46303" xml_f="46396" txt_i="26002" txt_f="26095">). However, VARA supplementation at neonatal age increased megalin mRNA approximate 10-fold (</offsets><italic><offsets xml_i="46404" xml_f="46405" txt_i="26095" txt_f="26096">P</offsets></italic><offsets xml_i="46414" xml_f="46570" txt_i="26096" txt_f="26249"> &lt; 0.01) in the adult kidney (blue bar). There was no effect of neonatal VARA treatment on megalin expression in adult rats (red bar). The expression of </offsets><italic><offsets xml_i="46578" xml_f="46582" txt_i="26249" txt_f="26253">Lrat</offsets></italic><offsets xml_i="46591" xml_f="46603" txt_i="26253" txt_f="26265"> in kidney (</offsets><xref rid="pone.0145924.g005" ref-type="fig"><offsets xml_i="46648" xml_f="46654" txt_i="26265" txt_f="26271">Fig 5B</offsets></xref><offsets xml_i="46661" xml_f="46710" txt_i="26271" txt_f="26320">) exhibited minimal changes during ontogeny, but </offsets><italic><offsets xml_i="46718" xml_f="46722" txt_i="26320" txt_f="26324">Lrat</offsets></italic><offsets xml_i="46731" xml_f="46958" txt_i="26324" txt_f="26551"> transcripts were dramatically increased by VARA in the early postnatal period (P1 and P4). After this time, no further response to VARA was observed, and early life VARA supplementation had no significant carry over effect on </offsets><italic><offsets xml_i="46966" xml_f="46970" txt_i="26551" txt_f="26555">Lrat</offsets></italic><offsets xml_i="46979" xml_f="47004" txt_i="26555" txt_f="26580"> expression in the adult.</offsets></p><fig id="pone.0145924.g005" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="47105" xml_f="47138" txt_i="26581" txt_f="26614">10.1371/journal.pone.0145924.g005</offsets></object-id><label><offsets xml_i="47157" xml_f="47162" txt_i="26614" txt_f="26619">Fig 5</offsets></label><caption><title><offsets xml_i="47186" xml_f="47212" txt_i="26619" txt_f="26645">Expression of megalin and </offsets><italic><offsets xml_i="47220" xml_f="47224" txt_i="26645" txt_f="26649">Lrat</offsets></italic><offsets xml_i="47233" xml_f="47326" txt_i="26649" txt_f="26742"> in kidney of neonatal rats and adult-age rats fed VAM diet and treated with or without VARA.</offsets></title><p><offsets xml_i="47337" xml_f="47403" txt_i="26743" txt_f="26809">Relative levels of mRNA transcripts are shown for megalin (A) and </offsets><italic><offsets xml_i="47411" xml_f="47419" txt_i="26809" txt_f="26817">Lrat (B)</offsets></italic><offsets xml_i="47428" xml_f="47483" txt_i="26817" txt_f="26872"> in kidney. under experimental conditions described in </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="47528" xml_f="47534" txt_i="26872" txt_f="26878">Fig 1A</offsets></xref><offsets xml_i="47541" xml_f="47621" txt_i="26878" txt_f="26958">. Asterisks (*) denote differences between oil and VARA groups in adult kidney, </offsets><italic><offsets xml_i="47629" xml_f="47630" txt_i="26958" txt_f="26959">P</offsets></italic><offsets xml_i="47639" xml_f="47766" txt_i="26959" txt_f="27083"> &lt; 0.05. Data are mean ± SEM, n ≥ 7/group. Abbreviations: P, postnatal day; VARA, vitamin A combined with 10% retinoic acid.</offsets></p></caption><graphic xlink:href="pone.0145924.g005"></graphic></fig></sec></sec><sec sec-type="conclusions" id="sec015"><title><offsets xml_i="47895" xml_f="47905" txt_i="27086" txt_f="27096">Discussion</offsets></title><p><offsets xml_i="47916" xml_f="49419" txt_i="27097" txt_f="28600">As our objectives in the current studies were to determine the natural ontogenic development of retinoid homeostatic gene expression in the neonatal to adult periods, and to understand the response of these major organs to VARA supplementation, at neonatal and adult ages, we determined tissue VA levels and the expression of major retinoid homeostatic genes in several organs at times from P1 to adult life. Although our primary interest was the lung, due to previous studies suggesting a benefit of RA or VARA on this tissue during alveolarization, we wanted to understand VARA supplementation in the larger context of several retinoid homeostatic organs. Thus, our studies including plasma, liver, lung and kidney, under the same experimental conditions, were designed to provide this context. The results of this study provide insight into VA homeostasis during the period of postnatal development, and suggest that supplementation with VARA, when administered to animals with marginal VA status, may influence their retinoid homeostatic gene system acutely, and also may have longer-term effects which can be observed as differences in the level of gene expression in adult animals that received VARA only as neonates. As our intention was to compare results at different ages and in responses to VARA supplementation, on both retinol concentrations and several genes in several tissues, numerous comparisons are of interest and, therefore, for convenience, we have summarized our main findings in </offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="49466" xml_f="49473" txt_i="28600" txt_f="28607">Table 2</offsets></xref><offsets xml_i="49480" xml_f="49717" txt_i="28607" txt_f="28844">. Several inferences or conclusions can be drawn from these results. First, based on the results of plasma, lung, and liver total retinol concentrations, the marginal VA status of the neonatal and adult rats in this study was confirmed (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="49762" xml_f="49767" txt_i="28844" txt_f="28849">Fig 1</offsets></xref><offsets xml_i="49774" xml_f="49937" txt_i="28849" txt_f="29012">). Interestingly, of these 3 tissues and although a VAM diet was fed to all rats after weaning, lung total retinol concentration increased (denoted as “higher” in </offsets><xref rid="pone.0145924.t001" ref-type="table"><offsets xml_i="49984" xml_f="49991" txt_i="29012" txt_f="29019">Table 1</offsets></xref><offsets xml_i="49998" xml_f="50303" txt_i="29019" txt_f="29324">) approximately 4-fold between neonatal (P10) and adult age. However, at the same time, the liver retinol concentration did not increase. This suggests that the lung has some priority for the uptake of retinol from plasma, as compared to liver. It is well known that VA is necessary for lung development [</offsets><xref rid="pone.0145924.ref022" ref-type="bibr"><offsets xml_i="50351" xml_f="50353" txt_i="29324" txt_f="29326">22</offsets></xref><offsets xml_i="50360" xml_f="50511" txt_i="29326" txt_f="29477">]. The low levels of VA in neonatal lung tissue could be due to increased utilization of retinoids for growth and postnatal alveolarization processes [</offsets><xref rid="pone.0145924.ref025" ref-type="bibr"><offsets xml_i="50559" xml_f="50561" txt_i="29477" txt_f="29479">25</offsets></xref><offsets xml_i="50568" xml_f="50570" txt_i="29479" txt_f="29481">].</offsets></p><table-wrap id="pone.0145924.t002" orientation="portrait" position="float"><object-id pub-id-type="doi"><offsets xml_i="50678" xml_f="50711" txt_i="29482" txt_f="29515">10.1371/journal.pone.0145924.t002</offsets></object-id><label><offsets xml_i="50730" xml_f="50737" txt_i="29515" txt_f="29522">Table 2</offsets></label><caption><title><offsets xml_i="50761" xml_f="50849" txt_i="29522" txt_f="29610">Summary of changes due to ontogeny and due to VARA treatment at neonatal and adult ages.</offsets></title></caption><alternatives><graphic id="pone.0145924.t002g" xlink:href="pone.0145924.t002"></graphic><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col><col align="left" valign="middle" span="1"></col></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"></th><th colspan="2" align="left" rowspan="1"><offsets xml_i="51414" xml_f="51449" txt_i="29611" txt_f="29646">Changes due to ontogeny (OIL group)</offsets></th><th colspan="3" align="left" rowspan="1"><offsets xml_i="51495" xml_f="51522" txt_i="29646" txt_f="29673">Response to VARA Treatments</offsets></th></tr><tr><th align="left" rowspan="1" colspan="1"></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="51623" xml_f="51664" txt_i="29673" txt_f="29714">Differences in neonatal stages, P1 to P10</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="51710" xml_f="51736" txt_i="29714" txt_f="29740">Adult age vs. neonatal age</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="51782" xml_f="51794" txt_i="29740" txt_f="29752">Neonatal age</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="51840" xml_f="51849" txt_i="29752" txt_f="29761">Adult Age</offsets></th><th align="left" rowspan="1" colspan="1"><offsets xml_i="51895" xml_f="51960" txt_i="29761" txt_f="29826">Carryover effect of neonatal VARA supplementation on adult levels</offsets></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="52036" xml_f="52050" txt_i="29826" txt_f="29840">Plasma Retinol</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52103" xml_f="52122" txt_i="29841" txt_f="29860">Nonsignificant (NS)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52168" xml_f="52170" txt_i="29861" txt_f="29863">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52216" xml_f="52225" txt_i="29864" txt_f="29873">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52271" xml_f="52273" txt_i="29874" txt_f="29876">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52319" xml_f="52321" txt_i="29877" txt_f="29879">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="52382" xml_f="52395" txt_i="29880" txt_f="29893">Liver Retinol</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52448" xml_f="52450" txt_i="29894" txt_f="29896">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52496" xml_f="52498" txt_i="29897" txt_f="29899">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52544" xml_f="52571" txt_i="29900" txt_f="29927">Increased dose-responsively</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52617" xml_f="52626" txt_i="29928" txt_f="29937">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52672" xml_f="52680" txt_i="29938" txt_f="29946">Positive</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="52741" xml_f="52753" txt_i="29947" txt_f="29959">Lung Retinol</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52806" xml_f="52808" txt_i="29960" txt_f="29962">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52854" xml_f="52860" txt_i="29963" txt_f="29969">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52906" xml_f="52915" txt_i="29970" txt_f="29979">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="52961" xml_f="52970" txt_i="29980" txt_f="29989">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53016" xml_f="53018" txt_i="29990" txt_f="29992">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="53079" xml_f="53085" txt_i="29993" txt_f="29999">Liver </offsets><italic><offsets xml_i="53093" xml_f="53097" txt_i="29999" txt_f="30003">Rbp4</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53159" xml_f="53161" txt_i="30004" txt_f="30006">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53207" xml_f="53213" txt_i="30007" txt_f="30013">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53259" xml_f="53266" txt_i="30014" txt_f="30021">Reduced</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53312" xml_f="53314" txt_i="30022" txt_f="30024">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53360" xml_f="53368" txt_i="30025" txt_f="30033">Negative</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="53429" xml_f="53435" txt_i="30034" txt_f="30040">Liver </offsets><italic><offsets xml_i="53443" xml_f="53447" txt_i="30040" txt_f="30044">Lrat</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53509" xml_f="53511" txt_i="30045" txt_f="30047">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53557" xml_f="53563" txt_i="30048" txt_f="30054">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53609" xml_f="53623" txt_i="30055" txt_f="30069">Increased (P4)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53669" xml_f="53701" txt_i="30070" txt_f="30099">Markedly increased (&gt;50-fold)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53747" xml_f="53755" txt_i="30100" txt_f="30108">Negative</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="53816" xml_f="53822" txt_i="30109" txt_f="30115">Liver </offsets><italic><offsets xml_i="53830" xml_f="53837" txt_i="30115" txt_f="30122">Cyp26A1</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53899" xml_f="53901" txt_i="30123" txt_f="30125">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53947" xml_f="53953" txt_i="30126" txt_f="30132">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="53999" xml_f="54014" txt_i="30133" txt_f="30148">Increased (P10)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54060" xml_f="54092" txt_i="30149" txt_f="30178">Markedly increased (&gt;50-fold)</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54138" xml_f="54140" txt_i="30179" txt_f="30181">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="54201" xml_f="54206" txt_i="30182" txt_f="30187">Lung </offsets><italic><offsets xml_i="54214" xml_f="54219" txt_i="30187" txt_f="30192">Stra6</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54281" xml_f="54283" txt_i="30193" txt_f="30195">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54329" xml_f="54331" txt_i="30196" txt_f="30198">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54377" xml_f="54386" txt_i="30199" txt_f="30208">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54432" xml_f="54434" txt_i="30209" txt_f="30211">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54480" xml_f="54482" txt_i="30212" txt_f="30214">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="54543" xml_f="54548" txt_i="30215" txt_f="30220">Lung </offsets><italic><offsets xml_i="54556" xml_f="54560" txt_i="30220" txt_f="30224">Lrat</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54622" xml_f="54624" txt_i="30225" txt_f="30227">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54670" xml_f="54676" txt_i="30228" txt_f="30234">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54722" xml_f="54731" txt_i="30235" txt_f="30244">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54777" xml_f="54779" txt_i="30245" txt_f="30247">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54825" xml_f="54833" txt_i="30248" txt_f="30256">Negative</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="54894" xml_f="54899" txt_i="30257" txt_f="30262">Lung </offsets><italic><offsets xml_i="54907" xml_f="54914" txt_i="30262" txt_f="30269">Cyp26B1</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="54976" xml_f="54978" txt_i="30270" txt_f="30272">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55024" xml_f="55026" txt_i="30273" txt_f="30275">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55072" xml_f="55081" txt_i="30276" txt_f="30285">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55127" xml_f="55129" txt_i="30286" txt_f="30288">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55175" xml_f="55183" txt_i="30289" txt_f="30297">Negative</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="55244" xml_f="55249" txt_i="30298" txt_f="30303">Lung </offsets><italic><offsets xml_i="55257" xml_f="55263" txt_i="30303" txt_f="30309">Raldh1</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55325" xml_f="55327" txt_i="30310" txt_f="30312">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55373" xml_f="55379" txt_i="30313" txt_f="30319">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55425" xml_f="55427" txt_i="30320" txt_f="30322">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55473" xml_f="55480" txt_i="30323" txt_f="30330">Reduced</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55526" xml_f="55528" txt_i="30331" txt_f="30333">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="55589" xml_f="55594" txt_i="30334" txt_f="30339">Lung </offsets><italic><offsets xml_i="55602" xml_f="55607" txt_i="30339" txt_f="30344">Raldh</offsets></italic><offsets xml_i="55616" xml_f="55617" txt_i="30344" txt_f="30345">2</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55670" xml_f="55672" txt_i="30346" txt_f="30348">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55718" xml_f="55720" txt_i="30349" txt_f="30351">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55766" xml_f="55768" txt_i="30352" txt_f="30354">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55814" xml_f="55821" txt_i="30355" txt_f="30362">Reduced</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="55867" xml_f="55875" txt_i="30363" txt_f="30371">Negative</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="55936" xml_f="55941" txt_i="30372" txt_f="30377">Lung </offsets><italic><offsets xml_i="55949" xml_f="55954" txt_i="30377" txt_f="30382">Raldh</offsets></italic><offsets xml_i="55963" xml_f="55964" txt_i="30382" txt_f="30383">3</offsets></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56017" xml_f="56019" txt_i="30384" txt_f="30386">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56065" xml_f="56071" txt_i="30387" txt_f="30393">Higher</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56117" xml_f="56119" txt_i="30394" txt_f="30396">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56165" xml_f="56167" txt_i="30397" txt_f="30399">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56213" xml_f="56215" txt_i="30400" txt_f="30402">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="56276" xml_f="56283" txt_i="30403" txt_f="30410">Kidney </offsets><italic><offsets xml_i="56291" xml_f="56298" txt_i="30410" txt_f="30417">Megalin</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56360" xml_f="56362" txt_i="30418" txt_f="30420">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56408" xml_f="56410" txt_i="30421" txt_f="30423">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56456" xml_f="56458" txt_i="30424" txt_f="30426">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56504" xml_f="56513" txt_i="30427" txt_f="30436">Increased</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56559" xml_f="56561" txt_i="30437" txt_f="30439">NS</offsets></td></tr><tr><td align="left" rowspan="1" colspan="1"><bold><offsets xml_i="56622" xml_f="56629" txt_i="30440" txt_f="30447">Kidney </offsets><italic><offsets xml_i="56637" xml_f="56641" txt_i="30447" txt_f="30451">Lrat</offsets></italic></bold></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56703" xml_f="56720" txt_i="30452" txt_f="30469">Higher only at P4</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56766" xml_f="56768" txt_i="30470" txt_f="30472">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56814" xml_f="56850" txt_i="30473" txt_f="30509">Increased, inverse dose-responsively</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56896" xml_f="56898" txt_i="30510" txt_f="30512">NS</offsets></td><td align="left" rowspan="1" colspan="1"><offsets xml_i="56944" xml_f="56952" txt_i="30513" txt_f="30521">Negative</offsets></td></tr></tbody></table></alternatives></table-wrap><p><offsets xml_i="57009" xml_f="57556" txt_i="30522" txt_f="31069">Secondly, there were significant age-related developmental patterns in the expression of retinoid homeostatic genes, mostly driven by differences that occurred between neonatal age and adult age. Our objective was to examine the patterns of expression of retinoid homeostatic genes in major VA storage/homeostatic organs (lung, liver, and kidney) throughout postnatal development, in rats nursed by dams fed VAM diet. As mentioned previously, we selected rats fed VAM diet for this study as a model for human population at risk for VA deficiency [</offsets><xref rid="pone.0145924.ref011" ref-type="bibr"><offsets xml_i="57604" xml_f="57606" txt_i="31069" txt_f="31071">11</offsets></xref><offsets xml_i="57613" xml_f="57669" txt_i="31071" txt_f="31127">]. Our results indicate that each of the genes examined–</offsets><italic><offsets xml_i="57677" xml_f="57681" txt_i="31127" txt_f="31131">Lrat</offsets></italic><offsets xml_i="57690" xml_f="57723" txt_i="31131" txt_f="31164"> (VA storage in liver and lung), </offsets><italic><offsets xml_i="57731" xml_f="57736" txt_i="31164" txt_f="31169">Stra6</offsets></italic><offsets xml_i="57745" xml_f="57767" txt_i="31169" txt_f="31191"> (VA uptake in lung), </offsets><italic><offsets xml_i="57775" xml_f="57779" txt_i="31191" txt_f="31195">Rbp4</offsets></italic><offsets xml_i="57788" xml_f="57864" txt_i="31195" txt_f="31271"> (VA trafficking from liver to plasma), megalin (VA recycling from plasma), </offsets><italic><offsets xml_i="57872" xml_f="57880" txt_i="31271" txt_f="31279">Raldh -1</offsets></italic><offsets xml_i="57889" xml_f="57891" txt_i="31279" txt_f="31281">, </offsets><italic><offsets xml_i="57899" xml_f="57901" txt_i="31281" txt_f="31283">-2</offsets></italic><offsets xml_i="57910" xml_f="57916" txt_i="31283" txt_f="31289">, and </offsets><italic><offsets xml_i="57924" xml_f="57926" txt_i="31289" txt_f="31291">-3</offsets></italic><offsets xml_i="57935" xml_f="57970" txt_i="31291" txt_f="31326"> (RA production from retinal), and </offsets><italic><offsets xml_i="57978" xml_f="57988" txt_i="31326" txt_f="31336">Cyp26A1/B1</offsets></italic><offsets xml_i="57997" xml_f="58192" txt_i="31336" txt_f="31531"> (RA terminal oxidation and degradation)–is expressed throughout the neonatal period. However, none of these changed significantly during the neonatal period (P1 to P10). However, interestingly, </offsets><italic><offsets xml_i="58200" xml_f="58204" txt_i="31531" txt_f="31535">Rbp4</offsets></italic><offsets xml_i="58213" xml_f="58224" txt_i="31535" txt_f="31546"> in liver, </offsets><italic><offsets xml_i="58232" xml_f="58236" txt_i="31546" txt_f="31550">Lrat</offsets></italic><offsets xml_i="58245" xml_f="58290" txt_i="31550" txt_f="31595"> in both the liver and lungs, in addition to </offsets><italic><offsets xml_i="58298" xml_f="58303" txt_i="31595" txt_f="31600">Stra6</offsets></italic><offsets xml_i="58312" xml_f="58318" txt_i="31600" txt_f="31606">, and </offsets><italic><offsets xml_i="58326" xml_f="58334" txt_i="31606" txt_f="31614">Raldh -1</offsets></italic><offsets xml_i="58343" xml_f="58348" txt_i="31614" txt_f="31619"> and </offsets><italic><offsets xml_i="58356" xml_f="58364" txt_i="31619" txt_f="31627">Raldh -2</offsets></italic><offsets xml_i="58373" xml_f="58808" txt_i="31627" txt_f="32062"> in lungs, all displayed a developmental pattern of expression with a significant increase in adult rats compared to neonates. Therefore, retinol trafficking, storage, uptake, and retinoic acid production are not only dependent on dietary status but also on age. Neonates are constantly growing and therefore do not maintain a metabolic steady state; as a result, VA among other nutrients is in constant demand for proper development [</offsets><xref rid="pone.0145924.ref026" ref-type="bibr"><offsets xml_i="58856" xml_f="58858" txt_i="32062" txt_f="32064">26</offsets></xref><offsets xml_i="58865" xml_f="58970" txt_i="32064" txt_f="32169">]. Even though the VA status of the neonatal and adult rats in our study was marginal, the expression of </offsets><italic><offsets xml_i="58978" xml_f="58982" txt_i="32169" txt_f="32173">Rbp4</offsets></italic><offsets xml_i="58991" xml_f="58996" txt_i="32173" txt_f="32178"> and </offsets><italic><offsets xml_i="59004" xml_f="59008" txt_i="32178" txt_f="32182">Lrat</offsets></italic><offsets xml_i="59017" xml_f="59040" txt_i="32182" txt_f="32205"> mRNAs in liver and of </offsets><italic><offsets xml_i="59048" xml_f="59052" txt_i="32205" txt_f="32209">Lrat</offsets></italic><offsets xml_i="59061" xml_f="59171" txt_i="32209" txt_f="32319"> mRNA in lung increased from neonatal to adult age. These results suggest that VA tissue accumulation through </offsets><italic><offsets xml_i="59179" xml_f="59183" txt_i="32319" txt_f="32323">Lrat</offsets></italic><offsets xml_i="59192" xml_f="59228" txt_i="32323" txt_f="32359"> is dependent on both diet and age [</offsets><xref rid="pone.0145924.ref026" ref-type="bibr"><offsets xml_i="59276" xml_f="59278" txt_i="32359" txt_f="32361">26</offsets></xref><offsets xml_i="59285" xml_f="59721" txt_i="32361" txt_f="32797">]. They may also suggest that adults, who have a lower basal metabolic rate than neonates, are able to conserve dietary VA more efficiently and thereby are able to accumulate retinol in tissues, such as the lungs, even when the intake of dietary VA is below normal levels. Hence, for this reason, the amount of VA in the VAM diet may actually meet the biological requirement for VA in the adult animal, and that any excess VA is stored.</offsets></p><p><offsets xml_i="59728" xml_f="59915" txt_i="32798" txt_f="32985">Thirdly, VARA supplementation significantly increased the concentration of retinol in plasma, liver, and lung. These results were anticipated based on previous findings in neonatal rats [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="59963" xml_f="59964" txt_i="32985" txt_f="32986">3</offsets></xref><offsets xml_i="59971" xml_f="59973" txt_i="32986" txt_f="32988">, </offsets><xref rid="pone.0145924.ref005" ref-type="bibr"><offsets xml_i="60021" xml_f="60022" txt_i="32988" txt_f="32989">5</offsets></xref><offsets xml_i="60029" xml_f="60041" txt_i="32989" txt_f="33001">] and mice [</offsets><xref rid="pone.0145924.ref020" ref-type="bibr"><offsets xml_i="60089" xml_f="60091" txt_i="33001" txt_f="33003">20</offsets></xref><offsets xml_i="60098" xml_f="60100" txt_i="33003" txt_f="33005">, </offsets><xref rid="pone.0145924.ref021" ref-type="bibr"><offsets xml_i="60148" xml_f="60150" txt_i="33005" txt_f="33007">21</offsets></xref><offsets xml_i="60157" xml_f="60159" txt_i="33007" txt_f="33009">, </offsets><xref rid="pone.0145924.ref027" ref-type="bibr"><offsets xml_i="60207" xml_f="60209" txt_i="33009" txt_f="33011">27</offsets></xref><offsets xml_i="60216" xml_f="60846" txt_i="33011" txt_f="33641">], but no previous studies had addressed the effect of neonatal VARA supplementation on retinoid homeostasis in the adult animal. Here, we examined the possible effect of VARA supplementation on retinoid homeostatic gene expression at several times during the neonatal period, and in adults that had received VARA supplementation either acutely (6 h before tissue collection) or solely as neonates. Liver total retinol was higher, which was not unexpected as the amount of VA in VARA was based on an amount of VA given to children as a supplement that has been shown to reduce the rates of morbidity and mortality for 4–6 months [</offsets><xref rid="pone.0145924.ref001" ref-type="bibr"><offsets xml_i="60894" xml_f="60895" txt_i="33641" txt_f="33642">1</offsets></xref><offsets xml_i="60902" xml_f="60987" txt_i="33642" txt_f="33727">]. VARA may thus be anticipated to result in significant storage of VA in the liver. </offsets><italic><offsets xml_i="60995" xml_f="60999" txt_i="33727" txt_f="33731">Rbp4</offsets></italic><offsets xml_i="61008" xml_f="61229" txt_i="33731" txt_f="33952"> expression in the liver of neonates was significantly decreased after oral VARA supplementation. Previous studies of acute treatment with RA, or synthetic retinoids, have shown a reduction in RBP4 and retinol in plasma [</offsets><xref rid="pone.0145924.ref028" ref-type="bibr"><offsets xml_i="61277" xml_f="61279" txt_i="33952" txt_f="33954">28</offsets></xref><offsets xml_i="61286" xml_f="61288" txt_i="33954" txt_f="33956">, </offsets><xref rid="pone.0145924.ref029" ref-type="bibr"><offsets xml_i="61336" xml_f="61338" txt_i="33956" txt_f="33958">29</offsets></xref><offsets xml_i="61345" xml_f="61348" txt_i="33958" txt_f="33961">]. </offsets><italic><offsets xml_i="61356" xml_f="61360" txt_i="33961" txt_f="33965">Lrat</offsets></italic><offsets xml_i="61369" xml_f="61374" txt_i="33965" txt_f="33970"> and </offsets><italic><offsets xml_i="61382" xml_f="61389" txt_i="33970" txt_f="33977">Cyp26A1</offsets></italic><offsets xml_i="61398" xml_f="61533" txt_i="33977" txt_f="34112"> expression levels were directly correlated with VA and RA availability through VARA supplementation in both neonatal and adult liver (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="61578" xml_f="61583" txt_i="34112" txt_f="34117">Fig 2</offsets></xref><offsets xml_i="61590" xml_f="61593" txt_i="34117" txt_f="34120">). </offsets><italic><offsets xml_i="61601" xml_f="61605" txt_i="34120" txt_f="34124">Rbp4</offsets></italic><offsets xml_i="61614" xml_f="61712" txt_i="34124" txt_f="34222"> expression in the liver of neonates was significantly decreased after oral VARA supplementation (</offsets><xref rid="pone.0145924.g002" ref-type="fig"><offsets xml_i="61757" xml_f="61763" txt_i="34222" txt_f="34228">Fig 2A</offsets></xref><offsets xml_i="61770" xml_f="61775" txt_i="34228" txt_f="34233"> and </offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="61822" xml_f="61829" txt_i="34233" txt_f="34240">Table 2</offsets></xref><offsets xml_i="61836" xml_f="61905" txt_i="34240" txt_f="34309">). Previous studies have shown that oral treatment with RA increased </offsets><italic><offsets xml_i="61913" xml_f="61917" txt_i="34309" txt_f="34313">Lrat</offsets></italic><offsets xml_i="61926" xml_f="61931" txt_i="34313" txt_f="34318"> and </offsets><italic><offsets xml_i="61939" xml_f="61946" txt_i="34318" txt_f="34325">Cyp26A1</offsets></italic><offsets xml_i="61955" xml_f="61987" txt_i="34325" txt_f="34357"> expression in adult rat liver [</offsets><xref rid="pone.0145924.ref030" ref-type="bibr"><offsets xml_i="62035" xml_f="62037" txt_i="34357" txt_f="34359">30</offsets></xref><offsets xml_i="62044" xml_f="62107" txt_i="34359" txt_f="34422">]. Our results show similar effects of VARA supplementation on </offsets><italic><offsets xml_i="62115" xml_f="62119" txt_i="34422" txt_f="34426">Lrat</offsets></italic><offsets xml_i="62128" xml_f="62133" txt_i="34426" txt_f="34431"> and </offsets><italic><offsets xml_i="62141" xml_f="62148" txt_i="34431" txt_f="34438">Cyp26A1</offsets></italic><offsets xml_i="62157" xml_f="62208" txt_i="34438" txt_f="34489"> expression in both adult and neonatal liver, with </offsets><italic><offsets xml_i="62216" xml_f="62223" txt_i="34489" txt_f="34496">Cyp26A1</offsets></italic><offsets xml_i="62232" xml_f="62334" txt_i="34496" txt_f="34598"> expression exhibiting the greatest increase (denoted as “markedly higher” with ≥100 fold increase in </offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="62381" xml_f="62388" txt_i="34598" txt_f="34605">Table 2</offsets></xref><offsets xml_i="62395" xml_f="62424" txt_i="34605" txt_f="34634">). Although the secretion of </offsets><italic><offsets xml_i="62432" xml_f="62436" txt_i="34634" txt_f="34638">Rbp4</offsets></italic><offsets xml_i="62445" xml_f="62499" txt_i="34638" txt_f="34692"> is tightly regulated by the availability of retinol [</offsets><xref rid="pone.0145924.ref030" ref-type="bibr"><offsets xml_i="62547" xml_f="62549" txt_i="34692" txt_f="34694">30</offsets></xref><offsets xml_i="62556" xml_f="62558" txt_i="34694" txt_f="34696">, </offsets><xref rid="pone.0145924.ref031" ref-type="bibr"><offsets xml_i="62606" xml_f="62608" txt_i="34696" txt_f="34698">31</offsets></xref><offsets xml_i="62615" xml_f="62673" txt_i="34698" txt_f="34756">], our results suggest a significant decrease in neonatal </offsets><italic><offsets xml_i="62681" xml_f="62685" txt_i="34756" txt_f="34760">Rbp4</offsets></italic><offsets xml_i="62694" xml_f="62940" txt_i="34760" txt_f="35006"> expression levels after VARA supplementation. These results support previous findings of a significant reduction in the level of RBP protein in liver after treatment of adult rats with a synthetic retinoid, N-(4-hydroxyphenyl) retinamide (HPR) [</offsets><xref rid="pone.0145924.ref028" ref-type="bibr"><offsets xml_i="62988" xml_f="62990" txt_i="35006" txt_f="35008">28</offsets></xref><offsets xml_i="62997" xml_f="63007" txt_i="35008" txt_f="35018">], or RA [</offsets><xref rid="pone.0145924.ref030" ref-type="bibr"><offsets xml_i="63055" xml_f="63057" txt_i="35018" txt_f="35020">30</offsets></xref><offsets xml_i="63064" xml_f="63314" txt_i="35020" txt_f="35270">]. Collectively, these results may support the idea that the liver interprets the increase in available retinoids after VARA supplementation as a signal of the body’s VA adequacy and senses this increase as extrahepatic tissues having sufficient VA [</offsets><xref rid="pone.0145924.ref030" ref-type="bibr"><offsets xml_i="63362" xml_f="63364" txt_i="35270" txt_f="35272">30</offsets></xref><offsets xml_i="63371" xml_f="63373" txt_i="35272" txt_f="35274">, </offsets><xref rid="pone.0145924.ref032" ref-type="bibr"><offsets xml_i="63421" xml_f="63423" txt_i="35274" txt_f="35276">32</offsets></xref><offsets xml_i="63430" xml_f="63535" txt_i="35276" txt_f="35381">]. Consequently, the liver may reduce the production and flow of RBP. To maintain normal VA homeostasis, </offsets><italic><offsets xml_i="63543" xml_f="63547" txt_i="35381" txt_f="35385">Lrat</offsets></italic><offsets xml_i="63556" xml_f="63561" txt_i="35385" txt_f="35390"> and </offsets><italic><offsets xml_i="63569" xml_f="63576" txt_i="35390" txt_f="35397">Cyp26A1</offsets></italic><offsets xml_i="63585" xml_f="63715" txt_i="35397" txt_f="35527"> may be up-regulated to store the excess VA for later use and to remove excess RA, respectively. This collaborative regulation of </offsets><italic><offsets xml_i="63723" xml_f="63727" txt_i="35527" txt_f="35531">Lrat</offsets></italic><offsets xml_i="63736" xml_f="63741" txt_i="35531" txt_f="35536"> and </offsets><italic><offsets xml_i="63749" xml_f="63756" txt_i="35536" txt_f="35543">Cyp26A1</offsets></italic><offsets xml_i="63765" xml_f="63873" txt_i="35543" txt_f="35651"> via VA availability has been suggested based on observation in several other studies in adult rat tissues [</offsets><xref rid="pone.0145924.ref032" ref-type="bibr"><offsets xml_i="63921" xml_f="63923" txt_i="35651" txt_f="35653">32</offsets></xref><offsets xml_i="63930" xml_f="64003" txt_i="35653" txt_f="35726">]. Our work confirms these same observations during neonatal development.</offsets></p><p><offsets xml_i="64010" xml_f="64169" txt_i="35727" txt_f="35886">Fourth, the lung is also a VA storage organ, as well as a tissue that depends on adequate retinol and RA for proper alveolar septation in the neonatal period [</offsets><xref rid="pone.0145924.ref022" ref-type="bibr"><offsets xml_i="64217" xml_f="64219" txt_i="35886" txt_f="35888">22</offsets></xref><offsets xml_i="64226" xml_f="64228" txt_i="35888" txt_f="35890">, </offsets><xref rid="pone.0145924.ref025" ref-type="bibr"><offsets xml_i="64276" xml_f="64278" txt_i="35890" txt_f="35892">25</offsets></xref><offsets xml_i="64285" xml_f="64287" txt_i="35892" txt_f="35894">, </offsets><xref rid="pone.0145924.ref033" ref-type="bibr"><offsets xml_i="64335" xml_f="64337" txt_i="35894" txt_f="35896">33</offsets></xref><offsets xml_i="64344" xml_f="64345" txt_i="35896" txt_f="35897">–</offsets><xref rid="pone.0145924.ref036" ref-type="bibr"><offsets xml_i="64393" xml_f="64395" txt_i="35897" txt_f="35899">36</offsets></xref><offsets xml_i="64402" xml_f="64478" txt_i="35899" txt_f="35975">]. In our study, the expression in the lung of genes involved in VA uptake (</offsets><italic><offsets xml_i="64486" xml_f="64491" txt_i="35975" txt_f="35980">Stra6</offsets></italic><offsets xml_i="64500" xml_f="64532" txt_i="35980" txt_f="36012">) and the removal of excess RA (</offsets><italic><offsets xml_i="64540" xml_f="64547" txt_i="36012" txt_f="36019">Cyp26B1</offsets></italic><offsets xml_i="64556" xml_f="64708" txt_i="36019" txt_f="36171">) remained constant during the postnatal period; however, their expression was strongly up-regulated 6 h after VARA supplementation. On the other hand, </offsets><italic><offsets xml_i="64716" xml_f="64720" txt_i="36171" txt_f="36175">Lrat</offsets></italic><italic><offsets xml_i="64737" xml_f="64742" txt_i="36175" txt_f="36180">Stra6</offsets></italic><offsets xml_i="64751" xml_f="64753" txt_i="36180" txt_f="36182">, </offsets><italic><offsets xml_i="64761" xml_f="64765" txt_i="36182" txt_f="36186">Lrat</offsets></italic><offsets xml_i="64774" xml_f="64780" txt_i="36186" txt_f="36192">, and </offsets><italic><offsets xml_i="64788" xml_f="64795" txt_i="36192" txt_f="36199">Cyp26B1</offsets></italic><offsets xml_i="64804" xml_f="64821" txt_i="36199" txt_f="36216"> in P7 rat lung [</offsets><xref rid="pone.0145924.ref008" ref-type="bibr"><offsets xml_i="64869" xml_f="64870" txt_i="36216" txt_f="36217">8</offsets></xref><offsets xml_i="64877" xml_f="64879" txt_i="36217" txt_f="36219">, </offsets><xref rid="pone.0145924.ref013" ref-type="bibr"><offsets xml_i="64927" xml_f="64929" txt_i="36219" txt_f="36221">13</offsets></xref><offsets xml_i="64936" xml_f="65359" txt_i="36221" txt_f="36644">]. The regulatory effect of VARA supplementation on these genes was transient, as mRNA levels were significantly up-regulated 6 h after dose administration but had returned to near baseline levels 12 hours after VARA supplementation. Our current study that examined the response to VARA across the neonatal period indicates that VARA supplementation induces the expression of all three genes as early as P1. Interestingly, </offsets><italic><offsets xml_i="65367" xml_f="65372" txt_i="36644" txt_f="36649">Stra6</offsets></italic><offsets xml_i="65381" xml_f="65600" txt_i="36649" txt_f="36868"> displayed highest expression after oral VARA supplementation of newborn rats (P1), with a decrease in magnitude with age. It should also be noted that by P10, neonates had received VARA supplementation on 4 occasions (</offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="65645" xml_f="65651" txt_i="36868" txt_f="36874">Fig 1A</offsets></xref><offsets xml_i="65658" xml_f="65701" txt_i="36874" txt_f="36917">), so the attenuation of the expression of </offsets><italic><offsets xml_i="65709" xml_f="65714" txt_i="36917" txt_f="36922">Stra6</offsets></italic><offsets xml_i="65723" xml_f="65868" txt_i="36922" txt_f="37067"> to VARA supplementation with age could be the result of sufficient retinoid accumulation, resulting in a feedback effect on retinol uptake. For </offsets><italic><offsets xml_i="65876" xml_f="65883" txt_i="37067" txt_f="37074">Cyp26B1</offsets></italic><offsets xml_i="65892" xml_f="65991" txt_i="37074" txt_f="37173"> in the lung, expression was increased after VARA supplementation at all ages, similar to that for </offsets><italic><offsets xml_i="65999" xml_f="66004" txt_i="37173" txt_f="37178">Stra6</offsets></italic><offsets xml_i="66013" xml_f="66051" txt_i="37178" txt_f="37216">, with a decrease in the magnitude of </offsets><italic><offsets xml_i="66059" xml_f="66066" txt_i="37216" txt_f="37223">Cyp26B1</offsets></italic><offsets xml_i="66075" xml_f="66151" txt_i="37223" txt_f="37299"> response with age, especially in adults. This contrasts to the response of </offsets><italic><offsets xml_i="66159" xml_f="66166" txt_i="37299" txt_f="37306">Cyp26A1</offsets></italic><offsets xml_i="66175" xml_f="66407" txt_i="37306" txt_f="37538"> in liver, in which the greatest increase was observed in adult VARA-supplemented rats. Our results suggest that excess retinol availability due to accumulative VARA supplementation results in decreased uptake of VA in lung through </offsets><italic><offsets xml_i="66415" xml_f="66420" txt_i="37538" txt_f="37543">Stra6</offsets></italic><offsets xml_i="66429" xml_f="66490" txt_i="37543" txt_f="37604"> and less RA production through down-regulated expression of </offsets><italic><offsets xml_i="66498" xml_f="66503" txt_i="37604" txt_f="37609">Raldh</offsets></italic><offsets xml_i="66512" xml_f="66550" txt_i="37609" txt_f="37647">. Despite the significant increase in </offsets><italic><offsets xml_i="66558" xml_f="66562" txt_i="37647" txt_f="37651">Lrat</offsets></italic><offsets xml_i="66571" xml_f="66717" txt_i="37651" txt_f="37797"> expression after VARA supplementation, neonates at P4 (the beginning of alveolar septation in the rat) and P10 (middle of the septation period) [</offsets><xref rid="pone.0145924.ref033" ref-type="bibr"><offsets xml_i="66765" xml_f="66767" txt_i="37797" txt_f="37799">33</offsets></xref><offsets xml_i="66774" xml_f="66776" txt_i="37799" txt_f="37801">, </offsets><xref rid="pone.0145924.ref037" ref-type="bibr"><offsets xml_i="66824" xml_f="66826" txt_i="37801" txt_f="37803">37</offsets></xref><offsets xml_i="66833" xml_f="66864" txt_i="37803" txt_f="37834">] had the smallest increase in </offsets><italic><offsets xml_i="66872" xml_f="66876" txt_i="37834" txt_f="37838">Lrat</offsets></italic><offsets xml_i="66885" xml_f="67167" txt_i="37838" txt_f="38120"> expression compared to P1 and adult rats. This may imply that esterification and storage of retinol in response to the VARA dose was reduced in the middle neonatal period, which could be concomitant with an increased utilization of VA for proper lung septation and alveolarization.</offsets></p><p><offsets xml_i="67174" xml_f="67199" txt_i="38121" txt_f="38146">Fifth, the expression of </offsets><italic><offsets xml_i="67207" xml_f="67212" txt_i="38146" txt_f="38151">Raldh</offsets></italic><offsets xml_i="67221" xml_f="67459" txt_i="38151" txt_f="38389"> genes is often considered a surrogate indicator of RA production, as RA itself has a very short half-life and its production per se would be extremely difficult to measure in vivo. In our study, we represented RA production by examining </offsets><italic><offsets xml_i="67467" xml_f="67474" txt_i="38389" txt_f="38396">Raldh-1</offsets></italic><offsets xml_i="67483" xml_f="67485" txt_i="38396" txt_f="38398">, </offsets><italic><offsets xml_i="67493" xml_f="67495" txt_i="38398" txt_f="38400">-2</offsets></italic><offsets xml_i="67504" xml_f="67510" txt_i="38400" txt_f="38406">, and </offsets><italic><offsets xml_i="67518" xml_f="67520" txt_i="38406" txt_f="38408">-3</offsets></italic><offsets xml_i="67529" xml_f="67685" txt_i="38408" txt_f="38564"> expression in the lungs of neonatal and adult rats. RALDHs have been shown to be expressed in rodent organs, including the lung, throughout embryogenesis [</offsets><xref rid="pone.0145924.ref038" ref-type="bibr"><offsets xml_i="67733" xml_f="67735" txt_i="38564" txt_f="38566">38</offsets></xref><offsets xml_i="67742" xml_f="67881" txt_i="38566" txt_f="38705">]. In our study, the expression in these three genes in the lung differed during ontogeny, as well as in response to VARA supplementation. </offsets><italic><offsets xml_i="67889" xml_f="67896" txt_i="38705" txt_f="38712">Raldh-1</offsets></italic><offsets xml_i="67905" xml_f="67911" txt_i="38712" txt_f="38718"> and -</offsets><italic><offsets xml_i="67919" xml_f="67920" txt_i="38718" txt_f="38719">3</offsets></italic><offsets xml_i="67929" xml_f="67986" txt_i="38719" txt_f="38776"> expression levels increased from neonatal to adult age (</offsets><xref rid="pone.0145924.g004" ref-type="fig"><offsets xml_i="68031" xml_f="68036" txt_i="38776" txt_f="38781">Fig 4</offsets></xref><offsets xml_i="68043" xml_f="68048" txt_i="38781" txt_f="38786"> and </offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="68095" xml_f="68102" txt_i="38786" txt_f="38793">Table 2</offsets></xref><offsets xml_i="68109" xml_f="68193" txt_i="38793" txt_f="38877">). Previous research confirmed this age-dependent trend in mucosal dendritic cells [</offsets><xref rid="pone.0145924.ref039" ref-type="bibr"><offsets xml_i="68241" xml_f="68243" txt_i="38877" txt_f="38879">39</offsets></xref><offsets xml_i="68250" xml_f="68377" txt_i="38879" txt_f="39006">]. Interestingly, VARA supplementation, which acutely provides both VA and RA to the animals (see elevation in plasma retinol, </offsets><xref rid="pone.0145924.g001" ref-type="fig"><offsets xml_i="68422" xml_f="68428" txt_i="39006" txt_f="39012">Fig 1B</offsets></xref><offsets xml_i="68435" xml_f="68449" txt_i="39012" txt_f="39026">), suppressed </offsets><italic><offsets xml_i="68457" xml_f="68464" txt_i="39026" txt_f="39033">Raldh-1</offsets></italic><offsets xml_i="68473" xml_f="68478" txt_i="39033" txt_f="39038"> and </offsets><italic><offsets xml_i="68486" xml_f="68488" txt_i="39038" txt_f="39040">-2</offsets></italic><offsets xml_i="68497" xml_f="68636" txt_i="39040" txt_f="39179"> expression, but only in adults. Because RA acts as a ligand for nuclear transcription factors and its concentration is tightly regulated [</offsets><xref rid="pone.0145924.ref040" ref-type="bibr"><offsets xml_i="68684" xml_f="68686" txt_i="39179" txt_f="39181">40</offsets></xref><offsets xml_i="68693" xml_f="68695" txt_i="39181" txt_f="39183">, </offsets><xref rid="pone.0145924.ref041" ref-type="bibr"><offsets xml_i="68743" xml_f="68745" txt_i="39183" txt_f="39185">41</offsets></xref><offsets xml_i="68752" xml_f="68861" txt_i="39185" txt_f="39294">], this suppression may prevent the accumulation of an excess of endogenously formed RA. It may also be that </offsets><italic><offsets xml_i="68869" xml_f="68876" txt_i="39294" txt_f="39301">Raldh-1</offsets></italic><offsets xml_i="68885" xml_f="68891" txt_i="39301" txt_f="39307"> and -</offsets><italic><offsets xml_i="68899" xml_f="68900" txt_i="39307" txt_f="39308">2</offsets></italic><offsets xml_i="68909" xml_f="69025" txt_i="39308" txt_f="39424"> in the lung of neonates, compared to adults, were less regulated by VARA supplementation because the expression of </offsets><italic><offsets xml_i="69033" xml_f="69040" txt_i="39424" txt_f="39431">Cyp26B1</offsets></italic><offsets xml_i="69049" xml_f="69117" txt_i="39431" txt_f="39499"> after VARA supplementation was greater in neonates than in adults (</offsets><xref rid="pone.0145924.g003" ref-type="fig"><offsets xml_i="69162" xml_f="69167" txt_i="39499" txt_f="39504">Fig 3</offsets></xref><offsets xml_i="69174" xml_f="69179" txt_i="39504" txt_f="39509"> and </offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="69226" xml_f="69233" txt_i="39509" txt_f="39516">Table 2</offsets></xref><offsets xml_i="69240" xml_f="69242" txt_i="39516" txt_f="39518">).</offsets></p><p><offsets xml_i="69249" xml_f="69415" txt_i="39519" txt_f="39685">Sixth, the kidney is known to play an important role in retinoid homeostasis, contributing to about 50% of the total circulating pool of the RBP-ROH complex in rats [</offsets><xref rid="pone.0145924.ref009" ref-type="bibr"><offsets xml_i="69463" xml_f="69464" txt_i="39685" txt_f="39686">9</offsets></xref><offsets xml_i="69471" xml_f="69494" txt_i="39686" txt_f="39709">]. Christensen et al. [</offsets><xref rid="pone.0145924.ref010" ref-type="bibr"><offsets xml_i="69542" xml_f="69544" txt_i="39709" txt_f="39711">10</offsets></xref><offsets xml_i="69551" xml_f="69597" txt_i="39711" txt_f="39757">] have demonstrated the importance of megalin </offsets><italic><offsets xml_i="69605" xml_f="69611" txt_i="39757" txt_f="39763">(Lrp2)</offsets></italic><offsets xml_i="69620" xml_f="70277" txt_i="39763" txt_f="40420"> for maintaining VA homeostasis. Approximately 5% of the circulating RBP-ROH complex is not bound to the co-transporter protein transthyretin, TTR, and is thus more readily filtered in the kidney and lost through urinary excretion. Interestingly, megalin is an LDL endocytic receptor protein for a variety of substances and vitamins, including VA and others, and is important for proximal tubular retinol reabsorption. Other researchers have shown that megalin is expressed during embryogenesis as early as day 4 of gestation and in adult kidneys, but have not examined the postnatal period. RA has also been shown to up-regulate the expression of megalin [</offsets><xref rid="pone.0145924.ref009" ref-type="bibr"><offsets xml_i="70325" xml_f="70326" txt_i="40420" txt_f="40421">9</offsets></xref><offsets xml_i="70333" xml_f="70335" txt_i="40421" txt_f="40423">, </offsets><xref rid="pone.0145924.ref010" ref-type="bibr"><offsets xml_i="70383" xml_f="70385" txt_i="40423" txt_f="40425">10</offsets></xref><offsets xml_i="70392" xml_f="70394" txt_i="40425" txt_f="40427">, </offsets><xref rid="pone.0145924.ref042" ref-type="bibr"><offsets xml_i="70442" xml_f="70444" txt_i="40427" txt_f="40429">42</offsets></xref><offsets xml_i="70451" xml_f="70467" txt_i="40429" txt_f="40445">]. Our results (</offsets><xref rid="pone.0145924.g005" ref-type="fig"><offsets xml_i="70512" xml_f="70517" txt_i="40445" txt_f="40450">Fig 5</offsets></xref><offsets xml_i="70524" xml_f="71054" txt_i="40450" txt_f="40980">) show that VARA supplementation did not alter the expression of megalin during ontogeny in the neonatal kidney, but significantly increased megalin expression in adult kidney. This may suggest that an excess of VA or RA, in the adult, triggers an increase in megalin expression that in turn contributes to enhanced uptake of retinol from plasma. Although megalin is generally considered part of a process of conservation, megalin might also contribute to removal of excess retinol under conditions of VA surplus. Our results for </offsets><italic><offsets xml_i="71062" xml_f="71066" txt_i="40980" txt_f="40984">Lrat</offsets></italic><offsets xml_i="71075" xml_f="71343" txt_i="40984" txt_f="41252"> expression in the kidney suggest that early life exposure to VARA may significantly upregulate the capacity for VA storage, but that responsiveness to VARA is lost as the neonate matures. These results not only add to information on the tissue specific regulation of </offsets><italic><offsets xml_i="71351" xml_f="71355" txt_i="41252" txt_f="41256">Lrat</offsets></italic><offsets xml_i="71364" xml_f="71535" txt_i="41256" txt_f="41427"> gene expression, but also are interesting in being similar to the response pattern of the lung, but contrasting for both tissues with the response of the liver, in which </offsets><italic><offsets xml_i="71543" xml_f="71547" txt_i="41427" txt_f="41431">Lrat</offsets></italic><offsets xml_i="71556" xml_f="71835" txt_i="41431" txt_f="41710"> expression was least responsive to VARA at the earliest ages examined. These results suggest that, early after birth, the kidney could play a more important role in VA storage. Interestingly, for some species (as studied at adult age) the kidney is a major organ of VA storage [</offsets><xref rid="pone.0145924.ref043" ref-type="bibr"><offsets xml_i="71883" xml_f="71885" txt_i="41710" txt_f="41712">43</offsets></xref><offsets xml_i="71892" xml_f="71894" txt_i="41712" txt_f="41714">].</offsets></p><p><offsets xml_i="71901" xml_f="72556" txt_i="41715" txt_f="42370">In addition to investigating the direct effect of VARA supplementation on retinol concentration and the ontogenic expression of retinoid homeostatic genes in VA storage tissues, we asked if there is a carryover effect of neonatal VARA supplementation in adult rats. The “VARA adult carry over” rats had been supplemented with VARA as neonates (up to P10) but they were not treated with VARA prior to euthanasia as adults. Our results demonstrated a carry over effect on tissue retinol concentration only in liver. Recent studies support our findings of longer maintenance of retinol levels in liver in comparison to extrahepatic tissues such as the lung [</offsets><xref rid="pone.0145924.ref003" ref-type="bibr"><offsets xml_i="72604" xml_f="72605" txt_i="42370" txt_f="42371">3</offsets></xref><offsets xml_i="72612" xml_f="72742" txt_i="42371" txt_f="42501">]. It is interesting to note that the VARA adult carryover rats displayed a significant decrease (denoted as “negative”) in liver </offsets><italic><offsets xml_i="72750" xml_f="72754" txt_i="42501" txt_f="42505">Rbp4</offsets></italic><offsets xml_i="72763" xml_f="72780" txt_i="42505" txt_f="42522">, liver and lung </offsets><italic><offsets xml_i="72788" xml_f="72792" txt_i="42522" txt_f="42526">Lrat</offsets></italic><offsets xml_i="72801" xml_f="72812" txt_i="42526" txt_f="42537">, and lung </offsets><italic><offsets xml_i="72820" xml_f="72827" txt_i="42537" txt_f="42544">Cyp26B1</offsets></italic><offsets xml_i="72836" xml_f="72838" txt_i="42544" txt_f="42546"> (</offsets><xref rid="pone.0145924.t002" ref-type="table"><offsets xml_i="72885" xml_f="72892" txt_i="42546" txt_f="42553">Table 2</offsets></xref><offsets xml_i="72899" xml_f="73570" txt_i="42553" txt_f="43224">), in comparison to both control (oil-treated) rats and adult rats that received VARA 6 h prior to euthanasia. While VARA can be said to push excess VA towards esterification and oxidation to maintain homeostasis, it may be that by adulthood gene expression for this purpose is no longer needed. In addition, the lack of a carryover effect of neonatal VARA supplementation on adult-age megalin expression suggests that this would likely be a short-term regulatory mechanism. At present, we do not have an explanation for these results, however further studies are needed to characterize these changes as they have implications for the use of retinoid therapy in neonates.</offsets></p></sec><sec sec-type="conclusions" id="sec016"><title><offsets xml_i="73627" xml_f="73638" txt_i="43226" txt_f="43237">Conclusions</offsets></title><p><offsets xml_i="73649" xml_f="74202" txt_i="43238" txt_f="43791">In summary, our results show a postnatal developmental pattern of total retinol concentration and expression of genes that regulate retinoid homeostasis in plasma and VA storage organs such as the lung, liver, and kidney in rats. In addition, we have shown that oral supplementation of VA in conjunction with 10% RA can alter total retinol availability and gene expression. Although we are uncertain whether the regulation of these genes in neonates is beneficial, we have gained insight on how neonatal VA supplementation regulates recycling (megalin, </offsets><italic><offsets xml_i="74210" xml_f="74214" txt_i="43791" txt_f="43795">Lrp2</offsets></italic><offsets xml_i="74223" xml_f="74239" txt_i="43795" txt_f="43811">), trafficking (</offsets><italic><offsets xml_i="74247" xml_f="74251" txt_i="43811" txt_f="43815">Rbp4</offsets></italic><offsets xml_i="74260" xml_f="74272" txt_i="43815" txt_f="43827">), storage (</offsets><italic><offsets xml_i="74280" xml_f="74284" txt_i="43827" txt_f="43831">Lrat</offsets></italic><offsets xml_i="74293" xml_f="74324" txt_i="43831" txt_f="43862">), and oxidation of retinoids (</offsets><italic><offsets xml_i="74332" xml_f="74337" txt_i="43862" txt_f="43867">Raldh</offsets></italic><offsets xml_i="74346" xml_f="74352" txt_i="43867" txt_f="43873">s and </offsets><italic><offsets xml_i="74360" xml_f="74365" txt_i="43873" txt_f="43878">Cyp26</offsets></italic><offsets xml_i="74374" xml_f="74846" txt_i="43878" txt_f="44350">s). It has been of great interest to determine whether neonatal treatment with VA or RA has any long-term benefit, or at least no adverse effect, in those that have received supplementation at birth; therefore, we have sought to understand the possible long-term effects of neonatal oral supplementation with VARA. The results from this study may help inform the clinical treatment of VA deficiency diseases and the development of nutritional recommendations for neonates.</offsets></p></sec></body><back><ack><p>We thank Dr. Reza Zolfaghari and Dr. Nan-Qian Li for their helpful advice and assistance.</p></ack><ref-list><title>References</title><ref id="pone.0145924.ref001"><label>1</label><mixed-citation publication-type="book"><collab>World Health Organization</collab>. <source>Guideline for vitamin A supplementation in infants 1–5 months of age</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>,; <year>2011</year> Available from: WHO <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_infants_1-5/en/NCBI">http://www.who.int/nutrition/publications/micronutrients/guidelines/vas_infants_1-5/en/NCBI</ext-link>
<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/books/NBK131993/PDF">http://www.ncbi.nlm.nih.gov/books/NBK131993/PDF</ext-link>
<ext-link ext-link-type="uri" xlink:href="http://whqlibdoc.who.int/publications/2011/9789241501811_eng.pdf">http://whqlibdoc.who.int/publications/2011/9789241501811_eng.pdf</ext-link>.</mixed-citation></ref><ref id="pone.0145924.ref002"><label>2</label><mixed-citation publication-type="other">World Health Organization. Report: WHO technical consultation on vitamin A in newborn health: mechanistic studies, Geneva, Switzerland, 1–3 December 2009. Geneva: World Health Organization; 2012. iv, 108 p.</mixed-citation></ref><ref id="pone.0145924.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Tan</surname><given-names>L</given-names></name>, <name><surname>Wray</surname><given-names>AE</given-names></name>, <name><surname>Green</surname><given-names>MH</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Compartmental modeling of whole-body vitamin A kinetics in unsupplemented and vitamin A-retinoic acid-supplemented neonatal rats</article-title>. <source>J Lipid Res</source>. <year>2014</year>;<volume>55</volume>(<issue>8</issue>):<fpage>1738</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="pmid">24914038</pub-id></mixed-citation></ref><ref id="pone.0145924.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Ambalavanan</surname><given-names>N</given-names></name>, <name><surname>Zolfaghari</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>NQ</given-names></name>. <article-title>Vitamin A combined with retinoic acid increases retinol uptake and lung retinyl ester formation in a synergistic manner in neonatal rats</article-title>. <source>J Lipid Res</source>. <year>2006</year>;<volume>47</volume>(<issue>8</issue>):<fpage>1844</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="pmid">16685080</pub-id></mixed-citation></ref><ref id="pone.0145924.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Li</surname><given-names>NQ</given-names></name>, <name><surname>Wu</surname><given-names>L</given-names></name>. <article-title>The components of VARA, a nutrient-metabolite combination of vitamin A and retinoic acid, act efficiently together and separately to increase retinyl esters in the lungs of neonatal rats</article-title>. <source>J Nutr</source>. <year>2006</year>;<volume>136</volume>(<issue>11</issue>):<fpage>2803</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="pmid">17056804</pub-id></mixed-citation></ref><ref id="pone.0145924.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Ambalavanan</surname><given-names>N</given-names></name>. <article-title>Retinoic acid combined with vitamin A synergizes to increase retinyl ester storage in the lungs of newborn and dexamethasone-treated neonatal rats</article-title>. <source>Neonatology</source>. <year>2007</year>;<volume>92</volume>(<issue>1</issue>):<fpage>26</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="pmid">17596734</pub-id></mixed-citation></ref><ref id="pone.0145924.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Li</surname><given-names>NQ</given-names></name>. <article-title>Retinol combined with retinoic acid increases retinol uptake and esterification in the lungs of young adult rats when delivered by the intramuscular as well as oral routes</article-title>. <source>J Nutr</source>. <year>2007</year>;<volume>137</volume>(<issue>11</issue>):<fpage>2371</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="pmid">17951472</pub-id></mixed-citation></ref><ref id="pone.0145924.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Inflammation induced by lipopolysaccharide does not prevent the vitamin A and retinoic acid-induced increase in retinyl ester formation in neonatal rat lungs</article-title>. <source>Br J Nutr</source>. <year>2012</year>:<fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation></ref><ref id="pone.0145924.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>EI</given-names></name>, <name><surname>Willnow</surname><given-names>TE</given-names></name>. <article-title>Essential role of megalin in renal proximal tubule for vitamin homeostasis</article-title>. <source>J Am Soc Nephrol</source>. <year>1999</year>;<volume>10</volume>(<issue>10</issue>):<fpage>2224</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="pmid">10505701</pub-id></mixed-citation></ref><ref id="pone.0145924.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>EI</given-names></name>, <name><surname>Moskaug</surname><given-names>JO</given-names></name>, <name><surname>Vorum</surname><given-names>H</given-names></name>, <name><surname>Jacobsen</surname><given-names>C</given-names></name>, <name><surname>Gundersen</surname><given-names>TE</given-names></name>, <name><surname>Nykjaer</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Evidence for an essential role of megalin in transepithelial transport of retinol</article-title>. <source>J Am Soc Nephrol</source>. <year>1999</year>;<volume>10</volume>(<issue>4</issue>):<fpage>685</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="pmid">10203351</pub-id></mixed-citation></ref><ref id="pone.0145924.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Tanumihardjo</surname><given-names>SA</given-names></name>. <article-title>Vitamin A: biomarkers of nutrition for development</article-title>. <source>Am J Clin Nutr</source>. <year>2011</year>;<volume>94</volume>(<issue>2</issue>):<fpage>658S</fpage>–<lpage>65S</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3945/ajcn.110.005777">10.3945/ajcn.110.005777</ext-link></comment>
<pub-id pub-id-type="pmid">21715511</pub-id></mixed-citation></ref><ref id="pone.0145924.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Zolfaghari</surname><given-names>R</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Acidic retinoids in small amounts promote retinyl ester formation in neonatal lung, with transient increases in retinoid homeostatic gene expression</article-title>. <source>Nutr Metab (Lond)</source>. <year>2013</year>;<volume>10</volume>(<issue>1</issue>):<fpage>72</fpage>.<pub-id pub-id-type="pmid">24351038</pub-id></mixed-citation></ref><ref id="pone.0145924.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>L</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Acidic retinoids synergize with vitamin A to enhance retinol uptake and STRA6, LRAT, and CYP26B1 expression in neonatal lung</article-title>. <source>J Lipid Res</source>. <year>2010</year>;<volume>51</volume>(<issue>2</issue>):<fpage>378</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1194/jlr.M001222">10.1194/jlr.M001222</ext-link></comment>
<pub-id pub-id-type="pmid">19700416</pub-id></mixed-citation></ref><ref id="pone.0145924.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Meng</surname><given-names>Z</given-names></name>, <name><surname>Xie</surname><given-names>J</given-names></name>. <article-title>Effects of sulfur dioxide on the expressions of EGF, EGFR, and COX-2 in airway of asthmatic rats</article-title>. <source>Arch Environ Contam Toxicol</source>. <year>2008</year>;<volume>54</volume>(<issue>4</issue>):<fpage>748</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="pmid">17962899</pub-id></mixed-citation></ref><ref id="pone.0145924.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Vonend</surname><given-names>O</given-names></name>, <name><surname>Apel</surname><given-names>T</given-names></name>, <name><surname>Amann</surname><given-names>K</given-names></name>, <name><surname>Sellin</surname><given-names>L</given-names></name>, <name><surname>Stegbauer</surname><given-names>J</given-names></name>, <name><surname>Ritz</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Modulation of gene expression by moxonidine in rats with chronic renal failure</article-title>. <source>Nephrol Dial Transplant</source>. <year>2004</year>;<volume>19</volume>(<issue>9</issue>):<fpage>2217</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="pmid">15266031</pub-id></mixed-citation></ref><ref id="pone.0145924.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Wray</surname><given-names>AE</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Perinatal exposure to vitamin A differentially regulates chondrocyte growth and the expression of aggrecan and matrix metalloprotein genes in the femur of neonatal rats</article-title>. <source>J Nutr</source>. <year>2012</year>;<volume>142</volume>(<issue>4</issue>):<fpage>649</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3945/jn.111.152660">10.3945/jn.111.152660</ext-link></comment>
<pub-id pub-id-type="pmid">22357747</pub-id></mixed-citation></ref><ref id="pone.0145924.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Cifelli</surname><given-names>CJ</given-names></name>, <name><surname>Zolfaghari</surname><given-names>R</given-names></name>, <name><surname>Li</surname><given-names>NQ</given-names></name>. <article-title>Multiple cytochrome P-450 genes are concomitantly regulated by vitamin A under steady-state conditions and by retinoic acid during hepatic first-pass metabolism</article-title>. <source>Physiol Genomics</source>. <year>2011</year>;<volume>43</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>67</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/physiolgenomics.00182.2010">10.1152/physiolgenomics.00182.2010</ext-link></comment>
<pub-id pub-id-type="pmid">21045116</pub-id></mixed-citation></ref><ref id="pone.0145924.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Massaro</surname><given-names>GD</given-names></name>, <name><surname>Massaro</surname><given-names>D</given-names></name>. <article-title>Retinoic acid treatment partially rescues failed septation in rats and in mice</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>. <year>2000</year>;<volume>278</volume>(<issue>5</issue>):<fpage>L955</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="pmid">10781425</pub-id></mixed-citation></ref><ref id="pone.0145924.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Massaro</surname><given-names>GD</given-names></name>, <name><surname>Massaro</surname><given-names>D</given-names></name>. <article-title>Postnatal treatment with retinoic acid increases the number of pulmonary alveoli in rats</article-title>. <source>Am J Physiol</source>. <year>1996</year>;<volume>270</volume>(<issue>2 Pt 1</issue>):<fpage>L305</fpage>–<lpage>10</lpage>. <pub-id pub-id-type="pmid">8780001</pub-id></mixed-citation></ref><ref id="pone.0145924.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>James</surname><given-names>ML</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Bulger</surname><given-names>A</given-names></name>, <name><surname>Philips</surname><given-names>JB</given-names></name>, <name><surname>Ambalavanan</surname><given-names>N</given-names></name>. <article-title>Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice</article-title>. <source>Pediatr Res</source>. <year>2010</year>;<volume>67</volume>(<issue>6</issue>):<fpage>591</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1203/PDR.0b013e3181dbac3d">10.1203/PDR.0b013e3181dbac3d</ext-link></comment>
<pub-id pub-id-type="pmid">20220550</pub-id></mixed-citation></ref><ref id="pone.0145924.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>James</surname><given-names>ML</given-names></name>, <name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Nicola</surname><given-names>T</given-names></name>, <name><surname>Steele</surname><given-names>C</given-names></name>, <name><surname>Ambalavanan</surname><given-names>N</given-names></name>. <article-title>VARA attenuates hyperoxia-induced impaired alveolar development and lung function in newborn mice</article-title>. <source>Am J Physiol Lung Cell Mol Physiol</source>. <year>2013</year>;<volume>304</volume>(<issue>11</issue>):<fpage>L803</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1152/ajplung.00257.2012">10.1152/ajplung.00257.2012</ext-link></comment>
<pub-id pub-id-type="pmid">23585226</pub-id></mixed-citation></ref><ref id="pone.0145924.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Maden</surname><given-names>M</given-names></name>. <article-title>Retinoids in lung development and regeneration</article-title>. <source>Curr Top Dev Biol</source>. <year>2004</year>;<volume>61</volume>:<fpage>153</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="pmid">15350401</pub-id></mixed-citation></ref><ref id="pone.0145924.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Ray</surname><given-names>WJ</given-names></name>, <name><surname>Bain</surname><given-names>G</given-names></name>, <name><surname>Yao</surname><given-names>M</given-names></name>, <name><surname>Gottlieb</surname><given-names>DI</given-names></name>. <article-title>CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family</article-title>. <source>J Biol Chem</source>. <year>1997</year>;<volume>272</volume>(<issue>30</issue>):<fpage>18702</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="pmid">9228041</pub-id></mixed-citation></ref><ref id="pone.0145924.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Zolfaghari</surname><given-names>R</given-names></name>. <article-title>Cytochrome P450s in the regulation of cellular retinoic acid metabolism</article-title>. <source>Annu Rev Nutr</source>. <year>2011</year>;<volume>31</volume>:<fpage>65</fpage>–<lpage>87</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1146/annurev-nutr-072610-145127">10.1146/annurev-nutr-072610-145127</ext-link></comment>
<pub-id pub-id-type="pmid">21529158</pub-id></mixed-citation></ref><ref id="pone.0145924.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Maden</surname><given-names>M</given-names></name>, <name><surname>Hind</surname><given-names>M</given-names></name>. <article-title>Retinoic acid in alveolar development, maintenance and regeneration</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source>. <year>2004</year>;<volume>359</volume>(<issue>1445</issue>):<fpage>799</fpage>–<lpage>808</lpage>. <pub-id pub-id-type="pmid">15293808</pub-id></mixed-citation></ref><ref id="pone.0145924.ref026"><label>26</label><mixed-citation publication-type="book"><name><surname>Ross</surname><given-names>AC</given-names></name>. <source>Introduction to Vitamin A: A Nutritional and Life Cycle Perspective</source>. <publisher-loc>Champaign, IL</publisher-loc>: <publisher-name>American Oil Chemists’ Society Press</publisher-name>; <year>2005</year>.</mixed-citation></ref><ref id="pone.0145924.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Obrochta</surname><given-names>KM</given-names></name>, <name><surname>Kane</surname><given-names>MA</given-names></name>, <name><surname>Napoli</surname><given-names>JL</given-names></name>. <article-title>Effects of diet and strain on mouse serum and tissue retinoid concentrations</article-title>. <source>PLoS One</source>. <year>2014</year>;<volume>9</volume>(<issue>6</issue>):<fpage>e99435</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0099435">10.1371/journal.pone.0099435</ext-link></comment>
<pub-id pub-id-type="pmid">24911926</pub-id></mixed-citation></ref><ref id="pone.0145924.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Ritter</surname><given-names>SJ</given-names></name>, <name><surname>Smith</surname><given-names>JE</given-names></name>. <article-title>Multiple retinoids alter liver bile salt-independent retinyl ester-hydrolase activity, serum vitamin A and serum retinol-binding protein of rats</article-title>. <source>Biochim Biophys Acta</source>. <year>1996</year>;<volume>1291</volume>(<issue>3</issue>):<fpage>228</fpage>–<lpage>36</lpage>. <pub-id pub-id-type="pmid">8980637</pub-id></mixed-citation></ref><ref id="pone.0145924.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>JE</given-names></name>, <name><surname>Lawless</surname><given-names>DC</given-names></name>, <name><surname>Green</surname><given-names>MH</given-names></name>, <name><surname>Moon</surname><given-names>RC</given-names></name>. <article-title>Secretion of vitamin A and retinol-binding protein into plasma is depressed in rats by N-(4-hydroxyphenyl)retinamide (fenretinide)</article-title>. <source>J Nutr</source>. <year>1992</year>;<volume>122</volume>(<issue>10</issue>):<fpage>1999</fpage>–<lpage>2009</lpage>. <pub-id pub-id-type="pmid">1388202</pub-id></mixed-citation></ref><ref id="pone.0145924.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>, <name><surname>Zolfaghari</surname><given-names>R</given-names></name>. <article-title>Regulation of hepatic retinol metabolism: perspectives from studies on vitamin A status</article-title>. <source>J Nutr</source>. <year>2004</year>;<volume>134</volume>(<issue>1</issue>):<fpage>269S</fpage>–<lpage>75S</lpage>. <pub-id pub-id-type="pmid">14704332</pub-id></mixed-citation></ref><ref id="pone.0145924.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Noy</surname><given-names>N</given-names></name>. <article-title>Retinoid-binding proteins: mediators of retinoid action</article-title>. <source>Biochem J</source>. <year>2000</year>;<volume>348</volume>
<issue>Pt 3</issue>:<fpage>481</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="pmid">10839978</pub-id></mixed-citation></ref><ref id="pone.0145924.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>AC</given-names></name>. <article-title>Advances in retinoid research: mechanisms of cancer chemoprevention symposium introduction</article-title>. <source>J Nutr</source>. <year>2003</year>;<volume>133</volume>(<issue>1</issue>):<fpage>271S</fpage>–<lpage>2S</lpage>. <pub-id pub-id-type="pmid">12514307</pub-id></mixed-citation></ref><ref id="pone.0145924.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>Kumar</surname><given-names>VH</given-names></name>, <name><surname>Lakshminrusimha</surname><given-names>S</given-names></name>, <name><surname>El Abiad</surname><given-names>MT</given-names></name>, <name><surname>Chess</surname><given-names>PR</given-names></name>, <name><surname>Ryan</surname><given-names>RM</given-names></name>. <article-title>Growth factors in lung development</article-title>. <source>Adv Clin Chem</source>. <year>2005</year>;<volume>40</volume>:<fpage>261</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="pmid">16355925</pub-id></mixed-citation></ref><ref id="pone.0145924.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Mactier</surname><given-names>H</given-names></name>, <name><surname>Weaver</surname><given-names>LT</given-names></name>. <article-title>Vitamin A and preterm infants: what we know, what we don't know, and what we need to know</article-title>. <source>Arch Dis Child Fetal Neonatal Ed</source>. <year>2005</year>;<volume>90</volume>(<issue>2</issue>):<fpage>F103</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="pmid">15724031</pub-id></mixed-citation></ref><ref id="pone.0145924.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Shenai</surname><given-names>JP</given-names></name>, <name><surname>Chytil</surname><given-names>F</given-names></name>. <article-title>Vitamin A storage in lungs during perinatal development in the rat</article-title>. <source>Biol Neonate</source>. <year>1990</year>;<volume>57</volume>(<issue>2</issue>):<fpage>126</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="pmid">2310790</pub-id></mixed-citation></ref><ref id="pone.0145924.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Zachman</surname><given-names>RD</given-names></name>. <article-title>Role of vitamin A in lung development</article-title>. <source>J Nutr</source>. <year>1995</year>;<volume>125</volume>(<issue>6 Suppl</issue>):<fpage>1634S</fpage>–<lpage>8S</lpage>. <pub-id pub-id-type="pmid">7782917</pub-id></mixed-citation></ref><ref id="pone.0145924.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Burri</surname><given-names>PH</given-names></name>. <article-title>Structural aspects of postnatal lung development—alveolar formation and growth</article-title>. <source>Biol Neonate</source>. <year>2006</year>;<volume>89</volume>(<issue>4</issue>):<fpage>313</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="pmid">16770071</pub-id></mixed-citation></ref><ref id="pone.0145924.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Niederreither</surname><given-names>K</given-names></name>, <name><surname>Fraulob</surname><given-names>V</given-names></name>, <name><surname>Garnier</surname><given-names>JM</given-names></name>, <name><surname>Chambon</surname><given-names>P</given-names></name>, <name><surname>Dollé</surname><given-names>P</given-names></name>. <article-title>Differential expression of retinoic acid-synthesizing (RALDH) enzymes during fetal development and organ differentiation in the mouse</article-title>. <source>Mech Dev</source>. <year>2002</year>;<volume>110</volume>(<issue>1–2</issue>):<fpage>165</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="pmid">11744377</pub-id></mixed-citation></ref><ref id="pone.0145924.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Molenaar</surname><given-names>R</given-names></name>, <name><surname>Knippenberg</surname><given-names>M</given-names></name>, <name><surname>Goverse</surname><given-names>G</given-names></name>, <name><surname>Olivier</surname><given-names>BJ</given-names></name>, <name><surname>de Vos</surname><given-names>AF</given-names></name>, <name><surname>O'Toole</surname><given-names>T</given-names></name>, <etal>et al</etal>
<article-title>Expression of retinaldehyde dehydrogenase enzymes in mucosal dendritic cells and gut-draining lymph node stromal cells is controlled by dietary vitamin A</article-title>. <source>J Immunol</source>. <year>2011</year>;<volume>186</volume>(<issue>4</issue>):<fpage>1934</fpage>–<lpage>42</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.4049/jimmunol.1001672">10.4049/jimmunol.1001672</ext-link></comment>
<pub-id pub-id-type="pmid">21220692</pub-id></mixed-citation></ref><ref id="pone.0145924.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Brun</surname><given-names>PJ</given-names></name>, <name><surname>Yang</surname><given-names>KJ</given-names></name>, <name><surname>Lee</surname><given-names>SA</given-names></name>, <name><surname>Yuen</surname><given-names>JJ</given-names></name>, <name><surname>Blaner</surname><given-names>WS</given-names></name>. <article-title>Retinoids: Potent regulators of metabolism</article-title>. <source>Biofactors</source>. <year>2013</year>;<volume>39</volume>(<issue>2</issue>):<fpage>151</fpage>–<lpage>63</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1002/biof.1056">10.1002/biof.1056</ext-link></comment>
<pub-id pub-id-type="pmid">23281051</pub-id></mixed-citation></ref><ref id="pone.0145924.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Bastien</surname><given-names>J</given-names></name>, <name><surname>Rochette-Egly</surname><given-names>C</given-names></name>. <article-title>Nuclear retinoid receptors and the transcription of retinoid-target genes</article-title>. <source>Gene</source>. <year>2004</year>;<volume>328</volume>:<fpage>1</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="pmid">15019979</pub-id></mixed-citation></ref><ref id="pone.0145924.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>Christensen</surname><given-names>EI</given-names></name>, <name><surname>Verroust</surname><given-names>PJ</given-names></name>. <article-title>Megalin and cubilin, role in proximal tubule function and during development</article-title>. <source>Pediatr Nephrol</source>. <year>2002</year>;<volume>17</volume>(<issue>12</issue>):<fpage>993</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="pmid">12478347</pub-id></mixed-citation></ref><ref id="pone.0145924.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Raila</surname><given-names>J</given-names></name>, <name><surname>Buchholz</surname><given-names>I</given-names></name>, <name><surname>Aupperle</surname><given-names>H</given-names></name>, <name><surname>Raila</surname><given-names>G</given-names></name>, <name><surname>Schoon</surname><given-names>HA</given-names></name>, <name><surname>Schweigert</surname><given-names>FJ</given-names></name>. <article-title>The distribution of vitamin A and retinol-binding protein in the blood plasma, urine, liver and kidneys of carnivores</article-title>. <source>Vet Res</source>. <year>2000</year>;<volume>31</volume>(<issue>6</issue>):<fpage>541</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="pmid">11129798</pub-id></mixed-citation></ref></ref-list></back></article>